“Creating Radiation and Chemical
Sniffing Drones and Innovative Detection Solutions for the Nuclear Energy, Medical and Emergency Response Markets.”


 





 


$2,100,000.00


 


Private Placement Offering Memorandum


 


7,000,000 Shares of Common Stock


 


$.30/Share with 35,000 Minimum Purchase


 


This Private Placement Offering
Memorandum (“PPM” or “Memorandum” or “Offering Memorandum” or “Offering”) is issued
by US Nuclear Corp., a Delaware corporation, doing business at 7051 Eton Avenue in Canoga Park, California 91303 (the “Company”).
The following exhibits are incorporated herein:


Exhibit AAccredited
Investor Questionnaire  


Exhibit B Subscription
Agreement


Exhibit CLink to
Annual Report for 2015 (Financial and Operational Disclosures)


Exhibit DBusiness
Presentation


Exhibit ECorporate
Resolutions: Offering Extensions


The Company has authorized
an increase in the number of shares being offered. The current resolution increases the number of shares from 2,000,000 shares
to 7,000,000. The resolution document authorizing the increase in shares is in Exhibit E of this Offering. The Company has updated
its business presentation as shown in Exhibit D to illustrate an up to date business projection.


The Company is making the
Offering only to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities
Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. This offering is being made
in reliance on exemptions from registration pursuant to Section 4(2) of the Securities Act and Rule 506(b) of Regulation D promulgated
thereunder and applicable state securities laws.





	1	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




The shares of common stock
will be sold pursuant to the terms of the Subscription Agreement (the “Subscription Agreement”) as described herein.
Pending completion of the Offering, all funds representing an investor’s common stock purchase will be placed on deposit
with the Company for immediate use pursuant to the Use of Funds schedule attached hereto. There is no impound requirement in this
offering and, as such, any funds received from this offering may be used by the Company at any time. The Company is currently listed
on the Over-The-Counter Bulletin Board exchange operated by the Financial Industry Regulatory Authority (“FINRA”) under
the symbol “UCLE”. We are DTC eligible under the rules promulgated by the Depository Trust and Clearing Corporation.
Our transfer agent is Action Stock Transfer located at 2469 E. Fort Union Blvd, Suite 214 in Salt Lake City, Utah 84121. The current
number of shares of issued and outstanding common stock in the Company is 13,947,403. All other financial and operational disclosures
can be found at the link set forth at Exhibit C or at www.sec.gov.


It is not the intent of
the Company, at this time, to register shares of common stock purchased under this Offering; however, general business practices
and internal decisions of the Board of Directors might dictate otherwise in the future. A public market currently exists for the
common stock of the Company, but it is limited, as set forth in the Company’s public filings. The Company cannot provide
any assurances regarding the common stock under this Offering, and the Company cannot assure that an active public market for any
of those securities will develop in the future. The Company’s stock is subject to restrictions on transferability and resale,
and may not be resold unless they are subsequently registered under the Securities Act and applicable state securities laws or
an exemption from registration is available.


There are certain perceived
benefits to being a reporting company. These are commonly thought to include the following: (a) increased visibility in the financial
community; (b) compliance with a requirement for admission to quotation on the OTC Bulletin Board or eventually on the Nasdaq Capital
Market; (c) the facilitation of borrowing from financial institutions; (d) increased valuation; (e) greater ease in raising capital;
(f) compensation of key employees through stock options for which there may be a market valuation; and (f) enhanced corporate image.
There are also certain perceived disadvantages to being a reporting company. These are commonly thought to include the following:
(a) requirement for audited financial statements; (b) required publication of corporate information; (c) required filings of periodic
and episodic reports with the SEC; and (d) increased rules and regulations governing management, corporate activities and shareholder
relations.


An
investment in the Company is speculative, involves a high degree of risk, and should be considered only by sophisticated investors
who can bear the economic risks of their investments for an indefinite period and who can afford to sustain a complete loss of
their investments. See “Risk Factors.”


 


In
making an investment decision, investors must rely on their own examination of the person or entity creating the securities and
the terms of the common stock offering herein, including the merits and risks involved. The securities offered hereby have not
been registered under the Securities Act or applicable state securities laws. These securities have not been approved or disapproved
by the United States Securities and Exchange Commission (the “SEC”), any state securities commission or other regulatory
authority. Furthermore, the foregoing authorities have not confirmed the accuracy or determined the adequacy of this document.
Any representation to the contrary is a criminal offense.


 


These
securities are subject to restrictions on transferability and resale and may not be transferred or resold except as permitted under
the Securities Act and the applicable state securities laws, pursuant to registration or exemption there from. Investors should
be aware that they will be required to bear the financial risks of this investment for an indefinite period of time.


 


This Memorandum is furnished on
a confidential basis to the person whose name appears on the cover page hereof (the “Offeree"). This Memorandum constitutes
an offer only to the Offeree and is provided to the Offeree solely for the purpose of evaluating an investment in the Company offered
hereby. By accepting delivery of this Memorandum, the Offeree agrees (i) to keep confidential the contents of this Memorandum and
any other oral or written information provided by the Company (directly or through one of its financial or legal advisors) in connection
with the offering and not to disclose the same to any third party or otherwise use the same for any purpose other than evaluating
an investment in the Company, (ii) not to copy, in whole or in part, this Memorandum or any other written information provided
by the Company (directly or through one of its financial or legal advisors) in connection herewith and (iii) to return this Memorandum
and any such written information to Robert I. Goldstein, the Company’s Chairman of the Board, Chief Executive Officer and
President, or its Counsel, Paesano Akkashian Apkarian, PC located at 7457 Franklin Road, Suite 200 in Bloomfield Hills, Michigan
48301, in the event that the Offeree does not subscribe to purchase any common stock pursuant to this offering, no portion of the
Offeree’s subscription is accepted or the Company’s offering is terminated or withdrawn.


 





	2	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017


 








    	



    	 



    




 


This Memorandum does not
constitute an offer to sell, or a solicitation of an offer to buy, any common stock offered hereby to any person in any jurisdiction
in which it is unlawful to make such an offer or solicitation to such person. Neither the delivery of this Memorandum nor any sale
made hereunder shall under any circumstance create any implication that the information contained herein is correct as of any date
subsequent to the date hereof.


The Company reserves the
right, in its sole discretion and for any reason whatsoever, to modify, amend, withdraw or terminate the Offering, including extending
the Offering buy no later than May 31, 2017, to accept or reject in whole or in part any prospective investment in the common stock
offered hereby, or to allot to the Offeree fewer than the number of shares of common stock the Offeree desires to purchase. The
Company shall have no liability whatsoever to the Offeree in the event that any of the foregoing shall occur.


In determining whether to
invest in the Company offering, the Offeree must rely upon his, her or its own examination of the Company and the terms of the
offering made hereby, including the merits and risks involved. The Company will, prior to the closing of the offering made hereby,
afford prospective investors an opportunity to ask questions of and to receive answers from the Company concerning the terms and
conditions of the offering and to obtain any additional relevant information which the Company possesses or can acquire without
unreasonable effort or expense. Except as aforesaid, no person is authorized in connection with the offering to give any information
or make any representation not contained in this Memorandum and, if given or made, such information or representation must not
be relied upon as having been authorized by the Company.


The Company makes no express
or implied representation or warranty as to the attainability of any forward looking statements or projections set forth herein
or as to the accuracy or completeness of the assumptions from which that projected information is derived. Projections of the Company’s
future performance are necessarily subject to a high degree of uncertainty, including certain factors set forth in the following
risk factors and elsewhere in this Memorandum, and the Company’s public filings, and actual results may vary materially and
adversely from any projections. It is expected that the Offeree will pursue its own independent investigation with respect to the
projected financial information included herein. Any estimates and projections contained herein have been prepared by the management
of the Company and involve significant elements of subjective judgment and analysis that may or may not be correct. Neither the
Company nor its financial or legal advisors makes any representation or warranty, express or implied, as to the accuracy or completeness
of the information contained in this document, and nothing contained herein is, or shall be relied upon as a warranty or representation,
whether as to past or future.


Forward
Looking Statements Disclosure and introduction to risk factors


 


This Offering Memorandum, including
the Use of Proceeds and Projections, below, and the Business Presentation at Exhibit D, contains forward-looking statements which
relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology
such as "may", "should", "expects", "plans", "anticipates", "believes",
"estimates", "predicts", "potential" or "continue" or the negative of these terms or other
comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors,
including the risks in the sections entitled "Risk Factors," that may cause our or our industry's actual results, levels
of activity, performance or achievements to be materially different from any future results, levels of activity, performance or
achievements expressed or implied by these forward-looking statements.


 


While these forward-looking statements,
and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction
of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions
or other future performance suggested herein. Except as required by applicable law, including the securities laws of the United
States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.


 


Although management believes that
the assumptions underlying the forward looking statements included in this filing are reasonable, they do not guarantee our future
performance, and actual results could differ from those contemplated by these forward looking statements. The assumptions used
for purposes of the forward-looking statements specified in the following information represent estimates of future events and
are subject to uncertainty as to possible changes in economic, legislative, industry, and other circumstances. As a result, the
identification and interpretation of data and other information and their use in developing and selecting assumptions from and
among reasonable alternatives require the exercise of judgment.


 





	3	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




To the extent that the assumed
events do not occur, the outcome may vary substantially from anticipated or projected results, and, accordingly, no opinion is
expressed on the achievability of those forward-looking statements. In the light of these risks and uncertainties, there can be
no assurance that the results and events contemplated by the forward-looking statements contained in this filing will in fact transpire.
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. We do not
undertake any obligation to update or revise any forward-looking statements.


 


Factors that might cause or contribute
to such differences include, but are not limited to, those discussed in "Risk Factors" contained in this Offering. As
a result of these factors, we cannot assure you that the forward-looking statements in this Offering will prove to be accurate.
Except as required by law, we expressly disclaim any obligation to update publicly any forward-looking statements for any reason
after the date of this report, to conform these statements to actual results, or to changes in our expectations. You should, however,
review the factors and risks we describe in the reports we will file from time to time with the SEC.


 


EXECUTIVE
SUMMARY – US NuCLEAR CORP.[1]


 


The Company incorporates by reference
its Annual Report on Form 10-K filed with the SEC on April 14, 2016 and its Quarterly Report on Form 10-Q filed on November 14,
2016. These reports, and all other reporting with the SEC at the link at Exhibit C, and on the Electronic Data Gathering, Analysis
and Retrieval portal managed by the SEC, commonly referred to as “EDGAR” set forth in detail the events leading up
to this Offering.


 


Although management believes that
the assumptions underlying the forward looking statements included in its public filings and this offering are reasonable, they
do not guarantee our future performance, and actual results could differ from those contemplated by these forward looking statements.
The assumptions used for purposes of the forward-looking statements specified in the following information represent estimates
of future events and are subject to uncertainty as to possible changes in economic, legislative, industry, and other circumstances.
As a result, the identification and interpretation of data and other information and their use in developing and selecting assumptions
from and among reasonable alternatives require the exercise of judgment.


 


To the extent that the assumed
events do not occur, the outcome may vary substantially from anticipated or projected results, and, accordingly, no opinion is
expressed on the achievability of those forward-looking statements. In the light of these risks and uncertainties, there can be
no assurance that the results and events contemplated by the forward-looking statements contained in this filing will in fact transpire.
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. We do not
undertake any obligation to update or revise any forward-looking statements.


 


Factors that might cause or contribute
to such differences include, but are not limited to, those discussed in this offering. As a result of these factors, we cannot
assure you that the forward-looking statements in this offering will prove to be accurate. Except as required by law, we expressly
disclaim any obligation to update publicly any forward-looking statements for any reason after the date of this report, to conform
these statements to actual results, or to changes in our expectations. You should, however, review the factors and risks we describe
in the reports we will file from time to time with the SEC after the date of this report.


 


Our Mission Is To Provide End-to-End
Solutions of Products and Services Globally And To 


Deliver Significant Value to Partners
and Shareholders




 


 











[1]
Also, please review Exhibit D for our Business Presentation






	4	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




Following a merger in October of
2013 with APEX 3, Inc., US Nuclear Acquisition Corp. and Optron Scientific Company, Inc. d/b/a Technical Associates (referred to
herein as “Technical Associates,” a related-party to the Company), we began to provide a full line of radiation detection
equipment and services to industries ranging from nuclear reactor plants, universities, local and state hospitals, government agencies,
and emergency medical technicians or EMT/first responders. The Company’s nuclear radiation safety detection equipment company
has its roots from the famous Manhattan Project of the 1940s. In 1971, Allen Goldstein, the father to our current President and
CEO, Robert Goldstein, acquired the assets of Technical Associates and incorporated the company. The Company designed and built
the first industrial grade radiation monitors and continues to innovate its legacy with new product engineering for radiation measurement
and safety instruments.


 


The Company designs and manufactures
nuclear radiation detection and safety equipment, survey meters, air and water monitors, port security equipment and tritium air
monitors. The Company’s customers are diverse groups such as Homeland Security, Lawrence Livermore Labs, Los Alamos National
Labs, Department of Defense, FBI, CIA, US Navy, Chevron Corporation, Bechtel Corporation, Biotechnology Laboratories, Hospitals,
Universities, and Civil Emergency Management departments such as Fire, Paramedics and Law Enforcement. The Company is headquartered
in Canoga Park, California and, in addition to its public filings, the Company’s information can be accessed through usnuclearcorp.com,
and through its related-party websites at tech-associates.com and overhoff.com.


 


Technology and Products


 


The Company designs and develops
both technologies in-house by its Chief Executive Officer, Robert I. Goldstein, as well as offers products from other manufacturers.
Mr. Goldstein’s extensive experience of over forty years in the field of nuclear radiation detection has allowed the Company
to achieve significant recognition. The Company has been approved by United States federal standards set by the Environmental Protection
Agency (EPA), Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC).


 


The Company has complete ownership
of all of its technology and there are no licenses held by any outside party. No persons, company, vendor, distributor or contractor
holds any title or claim to any of the Company’s work or technology. The Company believes that its technology and business
is defensible due to the fact that the barriers of entry are high and technically complex. The Company has sought out niche markets
in its business by becoming a leading category player in devices such as Tritium equipment. The Company’s products consist
of radiation water monitors, tritium monitors, air and water monitors, nano-second x-ray monitors, and vehicle, personnel, exit
and room monitors. The Company also offers handheld survey meters/dosimeters, and port security equipment, along with supporting
software and services.


 


Radiation Water Monitors


 


The Company’s radiation water
monitors allow detection of radioactive materials in drinking water, ground water, rainfall, rivers, and lakes. In order to detect
radioactive materials, the emitted radiation must travel from the radiation emitter to the detector. Alpha, Beta, Gamma, and Neutron
radiation moves well through air, but poorly through water. The complexity of detecting radiation in water and developing an efficient
monitor has given the Company’s monitors a reasonable edge against competitors, and for this reason, has limited competition
in the water monitor business. The Company has invested more than ten years developing highly sensitive detectors for this market,
giving it a clear advantage over competitors. The Company’s radiation water monitors are used to check for radioactive materials
being released as liquid effluent in drain pipes by universities, hospitals, pharmaceutical companies, oil and gas extraction facilities,
industrial chemical plants, and nuclear reactor plants.


 


Tritium Monitors


 


We are
one of very few companies that currently operate within the tritium space. Overhoff is a leading manufacturer of tritium detection
and monitors. The demand for tritium detection and monitors are steadily increasing as countries develop solutions to their energy
needs.  In addition to CANDU reactors (Canada Deuterium Uranium), the next generation of nuclear reactors called Molten
Salt Reactors, (MSR) and Liquid-Fluoride Thorium Reactors (LFTR) utilize fuels other than traditional uranium and plutonium sources.
Thorium, which is more significantly abundant than uranium, is very difficult to use to create nuclear weapons, is favored by many
governments, and as a source of conventional energy it has been proven to be highly effective. By way of energy production, MSR
and LFTRs produce high amounts of tritium which need to be constantly monitored for detection. Additionally, the waste products
of LFTR reactors are less hazardous than the current light-water uranium-plutonium reactors, and thus, LFTR reactors provide higher
level of safety and security against terrorist threats. The Company expects that a significant portion of its future sales and
business strategy is tied to the growth of MSR and LFTRs, as well as from CANDU reactors.


 





	5	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


Tritium
is produced naturally in the upper atmosphere when cosmic rays strike nitrogen molecules in the air. More commonly, tritium is
produced during nuclear weapons explosions, and as a byproduct in reactors producing electricity.  Generally, tritium
has several important uses; its most significant contribution is its use as a component in the triggering mechanism in thermonuclear
weapons. Very large quantities of required for the maintenance of nuclear weapons capabilities. Tritium is also produced commercially
in nuclear reactors, as well as used in various self-luminescent devices, such as exit signs in buildings, aircraft dials, gauges,
luminous paints, and wristwatches.


 


In the
mid-1950s and early 1960s, tritium was widely dispersed during above-ground testing of nuclear weapons. Today, sources of tritium
come from commercial nuclear reactors, research reactors, and government weapons production plants. Tritium may also be released
as steam from these facilities or may leak into the underlying soil and ground water. Additionally, self-luminescent devices illegally
disposed in municipal landfills come into contact with water which pass through water ways, carrying dangerous levels of tritium.
Tritium holds a very dangerous health risk and high levels of exposure to tritium increases risk of developing cancer. To combat
tritium leaks and to maintain acceptable levels, the Company has developed several tritium monitors to gauge tritium in water and
in the air. 


 


Alpha, Beta, Gamma and Tritium
Monitors


 


Our water monitors allow detection
of radioactive materials in drinking water, ground water, rainfall, rivers, and lakes. In order to detect radioactive materials,
the emitted radiation must travel from the radiation emitter to the detector. Alpha, Beta, Gamma, and Neutron radiation moves well
through air, but poorly through water. The complexity of detecting radiation in water and developing an efficient monitor has given
the Company’s monitors a reasonable edge against competitors, and for this reason, has limited competition in the water monitor
business. The Company has invested more than ten years developing highly sensitive detectors for this market, giving it a clear
advantage over competitors. The Company’s radiation water monitors are used to check for radioactive materials being released
as liquid effluent in drain pipes by universities, hospitals, pharmaceutical companies, oil and gas extraction facilities, industrial
chemical plants, and nuclear reactor plants.


 


For
the past 20 years, Overhoff has been devoted exclusively to the design, manufacturing and servicing of Tritium monitors. Overoff
has leading control over market share in the Tritium monitor space as the top maker of Tritium monitors. Tritium monitors are a
highly delicate process and are particularly dependent on the selection of the finest materials such as Teflon for low leakage
insulators and nafion membranes for separation of noble gas from Tritium. Overhoff DC amplifiers called “electrometers”
are stable with the ability to register small currents down to the femto-ampere level, 10-13 to
10-15ampre range. The Overhoff electrometer also has the
unique ability to reject false counts from Radon gas. Because Tritium is a radioactive material, the Nuclear Regulatory Commission
(“NRC”) regulations and state health agencies require Tritium to be measured at every nuclear power plant, all national
laboratories, in the nuclear powered Navies of the United States, France and the United Kingdom, at weapons facilities, at pharmaceutical
and pesticide research facilities, and at Fusion Power research sites.


 


Nano-Second X-Ray Monitors


 


The Company has introduced a hand
held TBM-IC-PLUSE-X survey meter for the US Navy. These new meters protect sailors and the general public from the new Nano-Second
X-Ray machines now being deployed to check for welding and corrosion flaws in military hardware from fighter jets to battle ships.


 


Air and Water Monitors


 


Our
Overhoff Air Monitors come in both hand-held portables and mid-to large-sized air and stack monitors. These are classified as Dual
Ion Chamber style detectors or Dual Proportional Detectors. The sample flows into one chamber where ionization current is measured,
and at the same time a sealed background detector of the same volume measures the ionization current due to any external gamma
emitters plus the addition of background from radioactive minerals in the soil with cosmic rays. The current from the background
chamber is subtracted from the current in the main sample chamber to give the net tritium level without distortion from radon or
gamma in the background. In nuclear power plants, radioactive noble gases are also in the air stream in small or large quantities.
Overhoff combats this problem using Dow Chemical Nafion® tubing
which physically separates the noble gases from the tritium oxide prior to measurement. The Company is currently expecting a large
number of its users and larger numbers of its competitor’s customers will need to replace or supplement their current air
and stack monitors to combat the two biggest pollution nuclides now coming out of nuclear power plants, tritium and C-14. As of
today, only US Nuclear Corp offers these full service monitors.


 





	6	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


Vehicle Monitors, Personnel
Monitors, Exit Monitors and Room Monitors


 


The Company’s suite of radiation
monitors can be used in various scenarios where humans may come into contact with radiation contamination. The Company’s
Vehicle Monitors, Personnel Monitors, Exit Monitors and Room Monitors are effective tools in detection of radiation in hospitals
where radioactivity is used in many departments such as nuclear medicine, oncology, blood labs, and imaging. Since radiation is
also used in diagnosing and treating cancer, and since some cancers can develop in any organ, each department in a hospital becomes
involved, from ophthalmology to thoracic medicine. Additionally, the Company’s monitors are used to check hospital laundry
to detect any radiation on clothes as well as in trash bins before they are picked up by the applicable waste management team.
Lastly, the Company’s monitors can be placed in the entrance of hospitals in case there is an incident at a nearby nuclear
power plant. These monitors are the first line of defense against further contamination, by providing early warning detection;
doctors can provide treatment without placing other patients and staff in direct contact with patients who are contaminated with
radiation.


 


Radon Air Monitors and Radon
Switch Products


 


The Company produces a full line
of radon air monitors and switches that are used to determine the radon content in the air in basements, mills, mines, buildings,
or anywhere that radon concentration is a concern. The radon switch products activate and controls radon mitigation fans. These
switches have a built-in computer storage with data storage. The Company also makes both radon tritium monitors that are portable
instruments used for detection and measurement of airborne Vadose zone, between the top of the ground surface to the water table.


 


Handheld Survey Meters and
Personal Dosimeters, Pocket Micro-R Meters


 


The Company’s survey meters
are light-weight, hand-held radiation detectors. They function as general purpose radiation survey meters, but also serve as special
purpose survey meters. For example, the Company’s radon monitors are used in mines where workers are at risk for breathing
radon gas along with air. The Company’s surface monitors are used in hospitals, research labs, even in high school chemistry
and physics labs to check for radioactive contamination on lab benches. Friskers are used to check if worker’s hands or shoe
bottoms have picked up any radiation contamination and the Company’s Gamma survey meter check packages at post offices or
airports for radiation, along with scrap metals at collection points and again before it is accepted for processing.


 


Port Security Equipment


 


Due to increased terror threats
from IED (Improvised Explosive Devices), dirty bombs and potential radioactive materials following 9/11 at shipping ports, we began
utilizing passive detectors to review radiation emanating from inside containers. While other port security scanners generally
use radioactive materials or x-ray generating machines to check everything from shipping containers, Federal Express, USPS (United
States Postal Service) packages, and luggage for contraband, our scanner solutions do not use radiation, allowing for safe usage
by investigators. We were approached by the FDA after the events of 9/11, and we designed our P-8Neon Quick-Scan X-ray detector
to provide complete scanning without releasing any harmful radiation in the process. Our RAD-CANSCAN machines can measure which
shipping containers hold radioactive materials by mapping inside the container so that TSA personnel will know the results without
having to open each container. Additionally, our TBM-6SPE is a multi-detector system that lets an investigator check specifically
for each of the four main emissions of radiation, Alpha, Beta, Gamma and Neutrons.


 


Drones with Airborne Radiation
Sensors


 


Model DroneRad quad- and hex-copters
carry radiation detectors. Chemical sensors and thermal hot spot imagers are planned as well. The market includes nuclear power
plants, anti-smuggling inspection teams, the National Laboratories, fire departments, first responders, mining companies, and environmental
agencies. These drones have the capability to navigate over areas of debris from an explosion, earthquake, flood, or any disaster.
A drone can move easily in areas too dangerous for humans, or too difficult for a robot to approach. Drones with high tech sensors
can fill a big hole in the ability to search dangerous areas, and to discover the exact location and current conditions at the
site of an explosion or a toxic/radioactive material leak. The portion of the biosphere that is more than 10 feet above the ground
is hard for us to monitor for toxic material. Drones can detect gases and contaminated air emerging from smokestacks or crossing
the property line of a chemical or nuclear plant, and allow one health physicist (or other professional) to view and measure over
mile wide radius from their position. These are measurements that cannot be made by using a computer simulation, ladder, or fixed
wing aircraft.


 





	7	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




Software


 


The Company’s Overhoff Overview
software program provides centralized radiation and environmental monitoring for entire facilities within one building or several
square miles allowing monitoring of a nuclear power plant or subway station. Overview accepts data from networked radiation detectors,
environmental monitors and webcams, and allows the user to view and generate reports on the data, as well as track maintenance
due on instruments. Additionally, Overview lets the user see real-time monitoring for differential pressure on containment boxes
or rooms. Our software measures gamma and neutron radiation levels, airborne radioactivity levels, temperature and humidity in
the facility, status of security doors, wind speed and direction, and barometric pressure.


 


TERMS OF OFFERING


 


The following summary of the Company Offering made
hereby is qualified in its entirety by the more detailed information appearing elsewhere in this Memorandum along with the appropriate
investor Subscription Agreement included with this Memorandum.


 


	 	List of Terms
	THE OFFERING:	Common Stocks. The Company is offering 7,000,000 shares of its common stock at $0.30/per share with a minimum purchase of 35,000 shares. The Company may be required to seek additional funding in the future through the issuance of equity or debt, either of which is likely to result in dilution to holders of the stock sold in the Offering.  The Company might utilize the services of a registered representative under the rules promulgated by FINRA to sell its shares, which might result in commissions being paid, and disclosed on Form D with the SEC.
	PURCHASERS:	
        The Offering is made to “Accredited Investors”
        only and as defined under the Securities Act, and a limited number of sophisticated investors.

         

	CAPITALIZATION:	
        Upon the Closing of the offering, the estimated capital
        structure of the Company, expressed in stock and fully diluted assuming the closing of the entirety of the offering shall be 20,475,000
        shares of common stock issued and outstanding.

         

	CLOSING:	
        The Company expects the closing of the offering to
        occur by or before May 31, 2017, or as soon thereafter as practicable and the Closing Date may be unilaterally extended by the
        Company without notice.

         

	
        SUBSCRIPTION AGREEMENT:

         
	
        All Investors in the common stock are required to execute
        the Investor Questionnaire and Subscription Agreement attached hereto. The Subscription Agreement sets for the terms and conditions
        of the purchase of the common stock and should be read carefully by each prospective investor.

         

	
        FINANCIAL STATEMENTS AND

        REPORTING:
	The Company will continue to submit financial statements consistent with the reporting requirements of the SEC. The Company will provide other customary information and materials, including, without limitation, reports of adverse developments, and communications with investors, press releases and effective registration statements through the appropriate filings.




 





	8	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    

USE
OF PROCEEDS


It
is the Company’s intention to use proceeds raised through the Offering as set forth in the chart below. To the extent
there are excess proceeds from the Offering, the Company intends on using such proceeds in furtherance of its business purpose,
as set forth herein. Regardless of the number of shares of common stock sold, the Company expects to
incur offering expenses estimated at $10,000 for legal, accounting, printing and other costs in connection with this offering.
We will not maintain an escrow account for the receipt of proceeds from the sale of our shares of common stock. 


 


	Application of Funds	If 25% of shares were sold	If 50% of shares were sold	If 75% of shares were sold	If 100% of shares were sold
	SALES AND MARKETING 	 	 	 	 
	Website Upgrade 	*	$30,000	$50,000	$50,000
	Trade Show Attendance	$60,000	$80,000	$170,000	$180,000
	Other Travel	$20,000	$30,000	$50,000	$60,000
	Sales Lead Tracking System/ Program	*	*	$40,000	$40,000
	Re-Approach Old Customers	$20,000	$20,000	$40,000	$60,000
	Advertising w/ an Emphasis On-Line	  $30,000	$40,000	$40,000	$40,000
	Upgrade to OTC-QX	* 	*	$20,000	$20,000
	 	 	 	 	 
	PRODUCT DEMOS TO CUSTOMERS AND OPINION LEADERS	$50,000	$130,000	$170,000	$170,000
	 	 	 	 	 
	BUILD STOCK	 	 	 	 
	Popular Products to Allow Quick Shipment	$70,000	$130,000	$150,000	$100,000
	Stand-Out Products for Demos 	$50,000	$100,000	$100,000	$100,000
	Common Sub-Assemblies Used in Bigger Products	$60,000	$100,000	$100,000	$100,000
	 	 	 	 	 
	DEVELOP NEW PRODUCTS	$60,000  	$270,000	$400,000	$800,000
	Radon Switch	 	 	 	 
	Tritium Sensitivity Break-Through Products	 	 	 	 
	Water Monitors	 	 	 	 
	 	 	 	 	 
	WORKING CAPITAL AND RESERVES 	$80,000	$70,000	$170,000	$380,000
	 	 	 	 	 
	TOTAL	$500,000	$1,000,000	$1,500,000	$2,100,000
	 	 	 	 	 


 





	9	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


PRojections
(2016-2019)


The projections set forth in Exhibit
D are forward-looking statements in reliance on the forward-looking disclosure above. These projections are subject to modification
without notice to you or any other shareholder. They are being provided merely as an educated, commercially reasonable assessment
of future growth.


 


Operational
and general business Risk Factors, and risks associated with our stock


The stock offered hereby
involves a high degree of risk. No one should invest who is not prepared to lose his, her, or its entire investment. There is no
active public market in the foreseeable future for the resale of the stock. Prospective investors, prior to making an investment,
should carefully examine the risk factors set forth in the Company’s public filings, and the risk factors set forth therein,
all of which are inherent in making an investment in, and affecting the business of, the Company, in addition to the other information
presented in this Memorandum. In the interests of conserving resources, and in the interests of maintaining consistency in our
disclosures to the public (and to you in this Offering), the Company is not going to restate prior public disclosures herein. However,
to the extent you do not have access to the internet, the Company is willing to provide you with printed documents for your review,
or review by your advisors. 


SECURITIES
Risk Factors AND suitability DISCLOSURES


INVESTORS SHALL BE REQUIRED TO
REPRESENT THAT THEY ARE FAMILIAR WITH AND UNDERSTAND THE TERMS, RISKS AND MERITS OF THE OFFERING DESCRIBED IN THIS MEMORANDUM AND
ALL THE ATTACHMENTS HERETO. THE COMMON STOCK IS BEING OFFERED IN A PRIVATE OFFERING TO A LIMITED NUMBER OF INDIVIDUALS OR ENTITIES
MEETING CERTAIN SUITABILITY STANDARDS. THIS OFFERING INVOLVES A HIGH DEGREE OF RISK AND PROSPECTIVE INVESTORS SHOULD BE AWARE THAT
THEY MAY SUSTAIN A LOSS OF THEIR ENTIRE INVESTMENT.



 


EXCLUSIVE NATURE OF THE PRIVATE PLACEMENT MEMORANDUM


 


NO ENTITY HAS BEEN AUTHORIZED
TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS MEMORANDUM. ANY INFORMATION OR REPRESENTATION
NOT CONTAINED HEREIN MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY THE COMPANY. MOREOVER, NEITHER THE DELIVERY OF THIS MEMORANDUM
NOR THE SALE OF THE COMMON STOCK SHALL UNDER ANY CIRCUMSTANCES CREATE ANY IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE MATTERS
DISCUSSED IN THIS MEMORANDUM SINCE THE DATE HEREOF; HOWEVER, IN THE EVENT OF ANY MATERIAL CHANGE OCCURRING PRIOR TO THE COMPLETION
OF THE OFFERING DESCRIBED HEREIN, THIS MEMORANDUM SHALL BE AMENDED AND REVISED ACCORDINGLY. THE COMPANY DISCLAIMS ANY AND ALL LIABILITIES
FOR REPRESENTATIONS OR WARRANTIES EXPRESSED OR IMPLIED, CONTAINED IN, OR OMISSIONS FROM, THIS MEMORANDUM, OR ANY OTHER WRITTEN
OR ORAL COMMUNICATION TRANSMITTED OR MADE AVAILABLE TO THE RECIPIENT. EACH INVESTOR SHALL BE ENTITLED TO RELY SOLELY ON THOSE REPRESENTATIONS
AND WARRANTIES WHICH MAY BE MADE TO THE INVESTOR IN ANY FINAL PURCHASE OR SUBSCRIPTION AGREEMENT RELATING TO THE COMMON STOCK.
THE DELIVERY OF THIS MEMORANDUM DOES NOT CONSTITUTE AN OFFER IN ANY JURISDICTION TO ANY PERSON TO WHOM SUCH OFFER WOULD BE UNLAWFUL
IN SUCH JURISDICTION.


 


THIS MEMORANDUM DOES NOT PURPORT
TO BE ALL-INCLUSIVE OR TO CONTAIN ALL OF THE INFORMATION THAT A PROSPECTIVE INVESTOR MAY DESIRE IN EVALUATING AN INVESTMENT IN
THE COMPANY. INVESTORS MUST CONDUCT AND RELY ON THEIR OWN EVALUATIONS OF THE COMPANY AND THE TERMS OF THE OFFERING, INCLUDING THE
MERITS AND RISKS INVOLVED IN MAKING AN INVESTMENT DECISION WITH RESPECT TO THE COMMON STOCK. THE RISK FACTORS DEFINED ABOVE SHOULD
BE CONSIDERED IN CONNECTION WITH THE PURCHASE OF THE COMMON STOCK. NEITHER THE DELIVERY OF THIS MEMORANDUM AT ANY TIME, NOR ANY
SALE OF THE COMMON STOCK HEREUNDER, SHALL UNDER ANY CIRCUMSTANCES CREATE AN IMPLICATION THAT THE INFORMATION CONTAINED IN THIS
MEMORANDUM IS CORRECT AS OF ANY TIME SUBSEQUENT TO ITS DATE.


 





	10	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017


 








    	



    	 



    




 


STATEMENT REGARDING FORWARD LOOKING PROJECTIONS


 


THE STATEMENTS, PROJECTIONS AND
ESTIMATES OF FUTURE PERFORMANCE OF THE COMPANY OR VARIOUS ELEMENTS OF THE COMPANY’S BUSINESS CONTAINED IN THIS MEMORANDUM
THAT ARE NOT HISTORICAL FACTS ARE FORWARD-LOOKING STATEMENTS. INVESTORS SHOULD EXPECT THAT ANTICIPATED EVENTS AND CIRCUMSTANCES
MAY NOT OCCUR, THAT UNANTICIPATED EVENTS AND CIRCUMSTANCES SHALL OCCUR, AND THAT ACTUAL RESULTS SHALL LIKELY VARY FROM THE FORWARD-LOOKING
CIRCUMSTANCES. INVESTORS SHOULD BE AWARE THAT A NUMBER OF FACTORS COULD CAUSE THE FORWARD-LOOKING STATEMENTS OR PROJECTIONS CONTAINED
IN THIS MEMORANDUM OR OTHERWISE MADE BY OR ON BEHALF OF THE COMPANY TO BE INCORRECT OR TO DIFFER MATERIALLY FROM ACTUAL RESULTS.
SUCH FACTORS MAY INCLUDE, WITHOUT LIMITATION, (i) THE ABILITY OF THE COMPANY TO PROVIDE SERVICES AND TO COMPLETE THE DEVELOPMENT
OF ITS PRODUCTS IN A TIMELY MANNER, (ii) THE DEMAND FOR AND TIMING OF DEMAND FOR SUCH SERVICES AND PRODUCTS, (iii) COMPETITION
FROM OTHER PRODUCTS AND COMPANIES, (iv) THE COMPANY’S SALES AND MARKETING CAPABILITIES, (v) THE COMPANY’S ABILITY TO
SELL ITS SERVICES AND PRODUCTS PROFITABLY, (vi) AVAILABILITY OF ADEQUATE DEBT AND EQUITY FINANCING, AND (vii) GENERAL BUSINESS
AND ECONOMIC CONDITIONS. THESE IMPORTANT FACTORS AND CERTAIN OTHER FACTORS THAT MIGHT AFFECT THE COMPANY’S FINANCIAL AND
BUSINESS RESULTS ARE DISCUSSED IN THIS MEMORANDUM UNDER “RISK FACTORS.” THERE CAN BE NO ASSURANCE THAT THE COMPANY
SHALL BE ABLE TO ANTICIPATE, RESPOND TO OR ADAPT TO CHANGES IN ANY FACTORS AFFECTING THE COMPANY’S BUSINESS AND FINANCIAL
RESULTS.


 


SAFE HARBOR STATEMENT UNDER


THE PRIVATE SECURITIES LITIGATION REFORM ACT


 


WITH THE EXCEPTION OF THE HISTORICAL
INFORMATION CONTAINED IN THIS DOCUMENT, THE MATTERS DESCRIBED HEREIN CONTAIN FORWARD-LOOKING STATEMENTS THAT INVOLVE RISK AND UNCERTAINTIES
THAT INDIVIDUALLY OR MUTUALLY IMPACT THE MATTERS HEREIN DESCRIBED INCLUDING, BUT NOT LIMITED TO, FINANCIAL PROJECTIONS, PRODUCT
DEMAND AND MARKET ACCEPTANCE, THE EFFECT OF ECONOMIC CONDITIONS, THE IMPACT OF COMPETITIVE PRODUCTS AND PRICING, GOVERNMENTAL REGULATIONS,
TECHNOLOGICAL DIFFICULTIES AND/OR OTHER FACTORS OUTSIDE THE CONTROL OF THE COMPANY.


 


DISCLAIMERS


 


THE COMMON STOCK OFFERED HEREBY
IN THIS OFFERING MEMORANDUM HAS NOT BEEN REGISTERED WITH, OR APPROVED, BY THE SEC, NOR HAS SUCH COMMON STOCK OR THIS MEMORANDUM
BEEN FILED WITH OR REVIEWED BY THE ATTORNEY GENERAL OF ANY STATE OR THE SECURITIES REGULATORY AUTHORITY OF ANY STATE. THIS OFFERING
IS BASED ON THE EXEMPTIONS FROM SUCH REGISTRATION AS SET FORTH IN §4(2) AND RULE 506 OF REGULATION D OF THE SECURITIES ACT
OF 1933, AS AMENDED.


 


THE INVESTMENT DESCRIBED IN THIS
MEMORANDUM INVOLVES RISKS, AND IS OFFERED ONLY TO INDIVIDUALS WHO CAN AFFORD TO ASSUME SUCH RISK FOR AN INDEFINITE PERIOD OF TIME
AND WHO AGREE TO PURCHASE THE COMMON STOCK ONLY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD THE TRANSFER, RESALE, EXCHANGE
OR FURTHER DISTRIBUTION THEREOF. THERE WILL BE NO PUBLIC MARKET FOR THE COMMON STOCK ISSUED PURSUANT TO THIS OFFERING MEMORANDUM.
THE RESALE OF THE COMMON STOCK IS LIMITED BY FEDERAL AND STATE SECURITIES LAWS AND IT IS THEREFORE RECOMMENDED THAT EACH POTENTIAL
INVESTOR SEEK COUNSEL SHOULD THEY DESIRE MORE INFORMATION.


 


THE PRICE OF THE COMMON STOCK
AS DESCRIBED IN THIS OFFERING MEMORANDUM HAS BEEN ARBITRARILY DETERMINED BY THE SPONSORS OF THIS INVESTMENT, AND EACH PROSPECTIVE
INVESTOR SHOULD MAKE AN INDEPENDENT EVALUATION OF THE FAIRNESS OF SUCH PRICE UNDER ALL THE CIRCUMSTANCES AS DESCRIBED IN THE ATTACHED
OFFERING MEMORANDUM. NO PERSON IS AUTHORIZED TO GIVE ANY INFORMATION OR MAKE ANY REPRESENTATION IN CONNECTION WITH THIS MEMORANDUM,
EXCEPT SUCH INFORMATION AS IS CONTAINED OR REFERENCED IN THIS MEMORANDUM. ONLY INFORMATION OR REPRESENTATIONS CONTAINED OR REFERENCED
HEREIN MAY BE RELIED UPON AS HAVING BEEN MADE BY THE COMPANY. PROSPECTIVE INVESTORS WHO HAVE QUESTIONS CONCERNING THE TERMS AND
CONDITIONS OF THIS PRIVATE OFFERING MEMORANDUM OR WHO DESIRE ADDITIONAL INFORMATION OR DOCUMENTATION TO VERIFY THE INFORMATION
CONTAINED HEREIN SHOULD CONTACT THE COMPANY. PROJECTIONS OR FORECASTS CONTAINED IN THIS PRIVATE OFFERING MEMORANDUM, OR OTHER MATERIALS,
MUST BE VIEWED ONLY AS ESTIMATES. ALTHOUGH ANY PROJECTIONS CONTAINED IN THIS MEMORANDUM ARE BASED UPON ASSUMPTIONS WHICH THE COMPANY
BELIEVES TO BE REASONABLE, THE ACTUAL PERFORMANCE OF THE COMPANY MAY DEPEND UPON FACTORS BEYOND THE CONTROL OF THE COMPANY. NO
ASSURANCE CAN BE GIVEN THAT THE COMPANY’S ACTUAL PERFORMANCE WILL MATCH ITS INTENDED RESULTS.


 





	11	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


Jurisdictional
(NASAA) Legends


 


FOR RESIDENTS OF ALL STATES: THE
PRESENCE OF A LEGEND FOR ANY GIVEN STATE REFLECTS ONLY THAT A LEGEND MAY BE REQUIRED BY THAT STATE AND SHOULD NOT BE CONSTRUED
TO MEAN AN OFFER OR SALE MAY BE MADE IN A PARTICULAR STATE. IF YOU ARE UNCERTAIN AS TO WHETHER OR NOT OFFERS OR SALES MAY BE LAWFULLY
MADE IN ANY GIVEN STATE, YOU ARE HEREBY ADVISED TO CONTACT THE COMPANY. THE SECURITIES DESCRIBED IN THIS MEMORANDUM HAVE NOT BEEN
REGISTERED UNDER ANY STATE SECURITIES LAWS (COMMONLY CALLED "BLUE SKY" LAWS). THESE SECURITIES MUST BE ACQUIRED FOR INVESTMENT
PURPOSES ONLY AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION OF SUCH SECURITIES UNDER SUCH LAWS,
OR AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.


 


THE PRESENCE OF A LEGEND FOR ANY
GIVEN STATE REFLECTS ONLY THAT A LEGEND MAY BE REQUIRED BY THE STATE AND SHOULD NOT BE CONSTRUED TO MEAN AN OFFER OF SALE MAY BE
MADE IN ANY PARTICULAR STATE. THE DISCLOSURES BELOW ARE SUBJECT TO REVISION OR MODIFICATION, AND THE INVESTOR IS ADVISED TO SEEK
INDEPENDENT LEGAL ADVICE IN THEIR JURISDICTION.


 


1. NOTICE TO ALABAMA RESIDENTS ONLY: THESE SECURITIES
ARE OFFERED PURSUANT TO A CLAIM OF EXEMPTION UNDER THE ALABAMA SECURITIES ACT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES
HAS NOT BEEN FILED WITH THE ALABAMA SECURITIES COMMISSION. THE COMMISSION DOES NOT RECOMMEND OR ENDORSE THE PURCHASE OF ANY SECURITIES,
NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF THIS PRIVATE PLACEMENT MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS
A CRIMINAL OFFENSE.


 


2. NOTICE TO ALASKA RESIDENTS ONLY: THE SECURITIES
OFFERED HAVE NOT BEEN REGISTERED WITH THE ADMINISTRATOR OF SECURITIES OF THE STATE OF ALASKA UNDER PROVISIONS OF 3 AAC 08.500-3
AAC 08.504. THE INVESTOR IS ADVISED THAT THE ADMINISTRATOR HAS NOT MADE A REVIEW OF THE REGISTRATION STATEMENT AND HAS NOT REVIEWED
THIS DOCUMENT SINCE THE DOCUMENT IS NOT REQUIRED TO BE FILED WITH THE ADMINISTRATOR. THE FACT OF REGISTRATION DOES NOT MEAN THAT
THE ADMINISTRATOR HAS PASSED IN ANY WAY UPON THE MERITS, RECOMMENDED, OR APPROVED THE SECURITIES. ANY REPRESENTATION TO THE CONTRARY
IS A VIOLATION OF 45.55.170. THE INVESTOR MUST RELY ON THE INVESTOR'S OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES
AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED IN MAKING AN INVESTMENT DECISION ON THESE SECURITIES.


 


3. NOTICE TO ARIZONA RESIDENTS ONLY: THESE SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE ARIZONA SECURITIES ACT IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION PURSUANT TO A.R.S. SECTION
44-1844 (1) AND THEREFORE CANNOT BE RESOLD UNLESS THEY ARE ALSO REGISTERED OR UNLESS AN EXEMPTION FROM REGISTRATION IS AVAILABLE.


 


4. NOTICE TO ARKANSAS RESIDENTS ONLY: THESE
SECURITIES ARE OFFERED IN RELIANCE UPON CLAIMS OF EXEMPTION UNDER THE ARKANSAS SECURITIES ACT AND SECTION 4(2) OF THE SECURITIES
ACT OF 1933. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS NOT BEEN FILED WITH THE ARKANSAS SECURITIES DEPARTMENT OR
WITH THE SECURITIES AND EXCHANGE COMMISSION. NEITHER THE DEPARTMENT NOR THE COMMISSION HAS PASSED UPON THE VALUE OF THESE SECURITIES,
MADE ANY RECOMMENDATIONS AS TO THEIR PURCHASE, APPROVED OR DISAPPROVED THIS OFFERING OR PASSED UPON THE ADEQUACY OR ACCURACY OF
THIS MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.


 


5. FOR CALIFORNIA RESIDENTS ONLY: THE SALE OF
THE SECURITIES WHICH ARE THE SUBJECT OF THIS OFFERING HAS NOT BEEN QUALIFIED WITH COMMISSIONER OF CORPORATIONS OF THE STATE OF
CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFORE PRIOR TO SUCH QUALIFICATIONS
IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPTED FROM QUALIFICATION BY SECTION 25100, 25102, OR 25104 OF THE CALIFORNIA CORPORATIONS
CODE. THE RIGHTS OF ALL PARTIES TO THIS OFFERING ARE EXPRESSLY CONDITION UPON SUCH QUALIFICATIONS BEING OBTAINED, UNLESS THE SALE
IS SO EXEMPT.


 





	12	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


6. FOR COLORADO RESIDENTS ONLY: THE SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE COLORADO SECURITIES ACT OF 1991 BY REASON OF SPECIFIC
EXEMPTIONS THEREUNDER RELATING TO THE LIMITED AVAILABILITY OF THE OFFERING. THESE SECURITIES CANNOT BE RESOLD, TRANSFERRED OR OTHERWISE
DISPOSED OF TO ANY PERSON OR ENTITY UNLESS SUBSEQUENTLY REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE COLORADO
SECURITIES ACT OF 1991, IF SUCH REGISTRATION IS REQUIRED.


 


7. NOTICE TO CONNECTICUT RESIDENTS ONLY: SHARES
ACQUIRED BY CONNECTICUT RESIDENTS ARE BEING SOLD AS A TRANSACTION EXEMPT UNDER SECTION 36-409(b)(9)(A) OF THE CONNECTICUT, UNIFORM
SECURITIES ACT. THE SHARES HAVE NOT BEEN REGISTERED UNDER SAID ACT IN THE STATE OF CONNECTICUT. ALL INVESTORS SHOULD BE AWARE THAT
THERE IS CERTAIN RESTRICTIONS AS TO THE TRANSFERABILITY OF THE SHARES.


 


8. NOTICE TO DELAWARE RESIDENTS ONLY: IF YOU
ARE A DELAWARE RESIDENT, YOU ARE HEREBY ADVISED THAT THESE SECURITIES ARE BEING OFFERED IN A TRANSACTION EXEMPT FROM THE REGISTRATION
REQUIREMENTS OF THE DELAWARE SECURITIES ACT. THE SECURITIES CANNOT BE SOLD OR TRANSFERRED EXCEPT IN A TRANSACTION WHICH IS EXEMPT
UNDER THE ACT OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR IN A TRANSACTION WHICH IS OTHERWISE IN COMPLIANCE
WITH THE ACT.


 


9. NOTICE TO DISTRICT OF COLUMBIA RESIDENTS ONLY:
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES BUREAU OF THE DISTRICT OF COLUMBIA NOR HAS THE COMMISSIONER
PASSED UPON THE ACCURACY OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.


 


10. NOTICE TO FLORIDA RESIDENTS ONLY: THE SHARES
DESCRIBED HEREIN HAVE NOT BEEN REGISTERED WITH THE FLORIDA DIVISION OF SECURITIES AND INVESTOR PROTECTION UNDER THE FLORIDA SECURITIES
ACT. THE SHARES REFERRED TO HEREIN WILL BE SOLD TO, AND ACQUIRED BY THE HOLDER IN A TRANSACTION EXEMPT UNDER SECTION 517.061 OF
SAID ACT. THE SHARES HAVE NOT BEEN REGISTERED UNDER SAID ACT IN THE STATE OF FLORIDA. IN ADDITION, ALL OFFEREES WHO ARE FLORIDA
RESIDENTS SHOULD BE AWARE THAT SECTION 517.061(11)(a)(5) OF THE ACT PROVIDES, IN RELEVANT PART, AS FOLLOWS: "WHEN SALES ARE
MADE TO FIVE OR MORE PERSONS IN [FLORIDA], ANY SALE IN [FLORIDA] MADE PURSUANT TO [THIS SECTION] IS VOIDABLE BY THE PURCHASER IN
SUCH SALE EITHER WITHIN 3 DAYS AFTER THE FIRST TENDER OF CONSIDERATION IS MADE BY THE PURCHASER TO THE ISSUER, AN AGENT OF THE
ISSUER OR AN ESCROW AGENT OR WITHIN 3 DAYS AFTER THE AVAILABILITY OF THAT PRIVILEGE IS COMMUNICATED TO SUCH PURCHASER, WHICHEVER
OCCURS LATER."


 


THE AVAILABILITY OF THE PRIVILEGE TO VOID SALES PURSUANT
TO SECTION 517.061(11) IS HEREBY COMMUNICATED TO EACH FLORIDA OFFEREE. EACH PERSON ENTITLED TO EXERCISE THE PRIVILEGE TO AVOID
SALES GRANTED BY SECTION 517.061 (11) (A)(5) AND WHO WISHES TO EXERCISE SUCH RIGHT, MUST, WITHIN 3 DAYS AFTER THE TENDER OF ANY
AMOUNT TO THE COMPANY OR TO ANY AGENT OF THE COMPANY (INCLUDING THE SELLING AGENT OR ANY OTHER DEALER ACTING ON BEHALF OF THE PARTNERSHIP
OR ANY SALESMAN OF SUCH DEALER) OR AN ESCROW AGENT CAUSE A WRITTEN NOTICE OR TELEGRAM TO BE SENT TO THE COMPANY AT THE ADDRESS
PROVIDED IN THIS CONFIDENTIAL EXECUTIVE SUMMARY. SUCH LETTER OR TELEGRAM MUST BE SENT AND, IF POSTMARKED, POSTMARKED ON OR PRIOR
TO THE END OF THE AFOREMENTIONED THIRD DAY. IF A PERSON IS SENDING A LETTER, IT IS PRUDENT TO SEND SUCH LETTER BY CERTIFIED MAIL,
RETURN RECEIPT REQUESTED, TO ASSURE THAT IT IS RECEIVED AND ALSO TO EVIDENCE THE TIME IT WAS MAILED. SHOULD A PERSON MAKE THIS
REQUEST ORALLY, HE MUST ASK FOR WRITTEN CONFIRMATION THAT HIS REQUEST HAS BEEN RECEIVED.


 


11. NOTICE TO GEORGIA RESIDENTS ONLY: THESE
SECURITIES ARE OFFERED IN A TRANSACTION EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE GEORGIA SECURITIES ACT PURSUANT TO REGULATION
590-4-5-04 AND -01. THE SECURITIES CANNOT BE SOLD OR TRANSFERRED EXCEPT IN A TRANSACTION WHICH IS EXEMPT UNDER THE ACT OR PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR IN A TRANSACTION WHICH IS OTHERWISE IN COMPLIANCE WITH THE ACT.


 





	13	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




12. NOTICE TO HAWAII RESIDENTS ONLY: NEITHER
THIS OFFERING NOR THE SECURITIES DESCRIBED HEREIN HAVE BEEN APPROVED OR DISAPPROVED BY THE COMMISSIONER OF SECURITIES OF THE STATE
OF HAWAII NOR HAS THE COMMISSIONER PASSED UPON THE ACCURACY OR ADEQUACY OF THIS OFFERING.


 


13. NOTICE TO IDAHO RESIDENTS ONLY: THESE SECURITIES
EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE IDAHO SECURITIES ACT IN RELIANCE UPON EXEMPTION FROM REGISTRATION PURSUANT
TO SECTION 30-14-203 OR 302(c) THEREOF AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT IN A TRANSACTION WHICH
IS EXEMPT UNDER SAID ACT OR PURSUANT TO AN EFFECTIVE REGISTRATION UNDER SAID ACT.


 


14. NOTICE TO ILLINOIS RESIDENTS: THESE SECURITIES
HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECRETARY OF THE STATE OF ILLINOIS NOR HAS THE STATE OF ILLINOIS PASSED UPON THE ACCURACY
OR ADEQUACY OF THE OFFERING. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.


 


15. NOTICE TO INDIANA RESIDENTS ONLY: THESE
SECURITIES ARE OFFERED PURSUANT TO A CLAIM OF EXEMPTION UNDER SECTION 23-2-1-2 OF THE INDIANA SECURITIES LAW AND HAVE NOT BEEN
REGISTERED UNDER SECTION 23-2-1-3. THEY CANNOT THEREFORE BE RESOLD UNLESS THEY ARE REGISTERED UNDER SAID LAW OR UNLESS AN EXEMPTION
FORM REGISTRATION IS AVAILABLE. A CLAIM OF EXEMPTION UNDER SAID LAW HAS BEEN FILED, AND IF SUCH EXEMPTION IS NOT DISALLOWED SALES
OF THESE SECURITIES MAY BE MADE. HOWEVER, UNTIL SUCH EXEMPTION IS GRANTED, ANY OFFER MADE PURSUANT HERETO IS PRELIMINARY AND SUBJECT
TO MATERIAL CHANGE.


 


16. NOTICE TO IOWA RESIDENTS ONLY: IN
MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND
THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED; THE FOREGOING AUTHORITIES
HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.
INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF
TIME.


 


17. NOTICE TO KANSAS RESIDENTS ONLY: IF AN INVESTOR
ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED
BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 81-5-6 OF THE KANSAS SECURITIES ACT AND MAY NOT BE RE-OFFERED
FOR SALE, TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 


18. NOTICE TO KENTUCKY RESIDENTS ONLY: IF AN
INVESTOR ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND
ACQUIRED BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER RULE 808 OF THE KENTUCKY SECURITIES ACT AND MAY NOT BE RE-OFFERED
FOR SALE, TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 


19. NOTICE TO LOUISIANA RESIDENTS ONLY: IF AN
INVESTOR ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND
ACQUIRED BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER RULE 1 OF THE LOUISIANA SECURITIES LAW AND MAY NOT BE RE-OFFERED
FOR SALE, TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 


20. NOTICE TO MAINE RESIDENTS ONLY: The
issuer is required to make a reasonable finding that the securities offered are a suitable investment for the purchaser and that
the purchaser is financially able to bear the risk of losing the entire amount invested. These securities are offered pursuant
to an EXEMPTION under §16202(15) of the Maine Uniform Securities Act and are not registered with the Securities Administrator
of the State of Maine. The securities offered for sale may be restricted securities and the holder may not be able to resell the
securities unless: (1) the securities are registered under state and federal securities laws, or (2)
an EXEMPTION is available under those laws.


 


	14	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




21. NOTICE TO MARYLAND RESIDENTS ONLY: IF YOU
ARE A MARYLAND RESIDENT AND YOU ACCEPT AN OFFER TO PURCHASE THESE SECURITIES PURSUANT TO THIS MEMORANDUM, YOU ARE HEREBY ADVISED
THAT THESE SECURITIES ARE BEING SOLD AS A TRANSACTION EXEMPT UNDER SECTION 11-602(9) OF THE MARYLAND SECURITIES ACT. THE SHARES
HAVE NOT BEEN REGISTERED UNDER SAID ACT IN THE STATE OF MARYLAND. ALL INVESTORS SHOULD BE AWARE THAT THERE ARE CERTAIN RESTRICTIONS
AS TO THE TRANSFERABILITY OF THE SHARES.


 


22. NOTICE TO MASSACHUSETTS RESIDENTS ONLY: THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE MASSACHUSETTS UNIFORM SECURITIES ACT,
BY REASON OF SPECIFIC EXEMPTIONS THEREUNDER RELATING TO THE LIMITED AVAILABILITY OF THIS OFFERING. THESE SECURITIES CANNOT BE SOLD,
TRANSFERRED, OR OTHERWISE DISPOSED OF TO ANY PERSON OR ENTITY UNLESS THEY ARE SUBSEQUENTLY REGISTERED OR AN EXEMPTION FROM REGISTRATION
IS AVAILABLE.


 


23. NOTICE TO MICHIGAN RESIDENTS ONLY: THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER SECTION 451.701 OF THE MICHIGAN UNIFORM SECURITIES ACT (THE ACT) AND MAY BE TRANSFERRED
OR RESOLD BY RESIDENTS OF MICHIGAN ONLY IF REGISTERED PURSUANT TO THE PROVISIONS OF THE ACT, OR IF AN EXEMPTION FROM REGISTRATION
IS AVAILABLE. THE INVESTMENT IS SUITABLE IF IT DOES NOT EXCEED 10% OF THE INVESTOR'S NET WORTH.


 


24. NOTICE TO MINNESOTA RESIDENTS ONLY: THESE
SECURITIES BEING OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER CHAPTER 80A OF THE MINNESOTA SECURITIES LAWS AND MAY NOT BE SOLD,
TRANSFERRED, OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO REGISTRATION, OR AN EXEMPTION THEREFROM.


 


25. NOTICE TO MISSISSIPPI RESIDENTS ONLY: THE
SHARES ARE OFFERED PURSUANT TO A CLAIM OF EXEMPTION UNDER THE MISSISSIPPI SECURITIES ACT. A REGISTRATION STATEMENT RELATING TO
THESE SECURITIES HAS NOT BEEN FILED WITH THE MISSISSIPPI SECRETARY OF STATE OR WITH THE SECURITIES AND EXCHANGE COMMISSION. NEITHER
THE SECRETARY OF STATE NOR THE COMMISSION HAS PASSED UPON THE VALUE OF THESE SECURITIES, OR APPROVED OR DISAPPROVED THIS OFFERING.
THE SECRETARY OF STATE DOES NOT RECOMMEND THE PURCHASE OF THESE OR ANY OTHER SECURITIES. EACH PURCHASER OF THE SECURITIES MUST
MEET CERTAIN SUITABILITY STANDARDS AND MUST BE ABLE TO BEAR AN ENTIRE LOSS OF THIS INVESTMENT. THE SECURITIES MAY NOT BE TRANSFERRED
FOR A PERIOD OF ONE (1) YEAR EXCEPT IN A TRANSACTION WHICH IS EXEMPT UNDER THE MISSISSIPPI SECURITIES ACT OR IN A TRANSACTION IN
COMPLIANCE WITH THE MISSISSIPPI SECURITIES ACT.


 


26. FOR MISSOURI RESIDENTS ONLY: THE SECURITIES
OFFERED HEREIN WILL BE SOLD TO, AND ACQUIRED BY, THE PURCHASER IN A TRANSACTION EXEMPT UNDER SECTION 4.G OF THE MISSOURI SECURITIES
LAW OF 1953, AS AMENDED. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER SAID ACT IN THE STATE OF MISSOURI. UNLESS THE SECURITIES
ARE SO REGISTERED, THEY MAY NOT BE OFFERED FOR SALE OR RESOLD IN THE STATE OF MISSOURI, EXCEPT AS A SECURITY, OR IN A TRANSACTION
EXEMPT UNDER SAID ACT.


 


27. NOTICE TO MONTANA RESIDENTS ONLY: IN ADDITION
TO THE INVESTOR SUITABILITY STANDARDS THAT ARE OTHERWISE APPLICABLE, ANY INVESTOR WHO IS A MONTANA RESIDENT MUST HAVE A NET WORTH
(EXCLUSIVE OF HOME, FURNISHINGS AND AUTOMOBILES) IN EXCESS OF FIVE (5) TIMES THE AGGREGATE AMOUNT INVESTED BY SUCH INVESTOR IN
THE SHARES.


 


28. NOTICE TO NEBRASKA RESIDENTS ONLY: IF AN
INVESTOR ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND
ACQUIRED BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER CHAPTER 15 OF THE NEBRASKA SECURITIES LAW AND MAY NOT BE
RE-OFFERED FOR SALE, TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 


29. NOTICE TO NEVADA RESIDENTS ONLY: IF ANY
INVESTOR ACCEPTS ANY OFFER TO PURCHASE THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED
BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 49:3-60(b) OF THE NEVADA SECURITIES LAW. THE INVESTOR IS
HEREBY ADVISED THAT THE ATTORNEY GENERAL OF THE STATE OF NEVADA HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING AND THE
FILING OF THE OFFERING WITH THE BUREAU OF SECURITIES DOES NOT CONSTITUTE APPROVAL OF THE ISSUE, OR SALE THEREOF, BY THE BUREAU
OF SECURITIES OR THE DEPARTMENT OF LAW AND PUBLIC SAFETY OF THE STATE OF NEVADA. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.
NEVADA ALLOWS THE SALE OF SECURITIES TO 25 OR FETHE COMPANYR PURCHASERS IN THE STATE WITHOUT REGISTRATION. HOWEVER, CERTAIN CONDITIONS
APPLY, I.E., THERE CAN BE NO GENERAL ADVERTISING OR SOLICITATION AND COMMISSIONS ARE LIMITED TO LICENSED BROKER-DEALERS. THIS EXEMPTION
IS GENERALLY USED WHERE THE PROSPECTIVE INVESTOR IS ALREADY KNOWN AND HAS A PRE-EXISTING RELATIONSHIP WITH THE COMPANY. (SEE NRS
90.530.11.)


 





	15	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017







 



    	



    	 



    




30. NOTICE TO NEW HAMPSHIRE RESIDENTS ONLY: NEITHER
THE FACT THAT A REGISTRATION STATEMENT OR AN APPLICATION FOR A LICENSE UNDER THIS CHAPTER HAS BEEN FILED WITH THE STATE OF NEW
HAMPSHIRE NOR THE FACT THAT A SECURITY IS EFFECTIVELY REGISTERED OR A PERSON IS LICENSED IN THE STATE OF NEW HAMPSHIRE CONSTITUTES
A FINDING BY THE SECRETARY OF STATE THAT ANY DOCUMENT FILED UNDER RSA 421-B IS TRUE, COMPLETE AND NOT MISLEADING. NEITHER ANY SUCH
FACT NOR THE FACT THAT AN EXEMPTION OR EXCETHE COMPANYON IS AVAILABLE FOR A SECURITY OR A TRANSACTION MEANS THAT THE SECRETARY
OF STATE HAS PASSED IN ANY WAY UPON THE MERITS OR QUALIFICATIONS OF, OR RECOMMENDED OR GIVEN APPROVAL TO, ANY PERSON, SECURITY,
OR TRANSACTION. IT IS UNLAWFUL TO MAKE, OR CAUSE TO BE MADE, TO ANY PROSPECTIVE PURCHASER, CUSTOMER, OR CLIENT ANY REPRESENTATION
INCONSISTENT WITH THE PROVISIONS OF THIS PARAGRAPH.


 


31. NOTICE TO NEW JERSEY RESIDENTS ONLY: IF
YOU ARE A NEW JERSEY RESIDENT AND YOU ACCEPT AN OFFER TO PURCHASE THESE SECURITIES PURSUANT TO THIS MEMORANDUM, YOU ARE HEREBY
ADVISED THAT THIS MEMORANDUM HAS NOT BEEN FILED WITH OR REVIEWED BY THE ATTORNEY GENERAL OF THE STATE OF NEW JERSEY PRIOR TO ITS
ISSUANCE AND USE. THE ATTORNEY GENERAL OF THE STATE OF NEW JERSEY HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY
REPRESENTATION TO THE CONTRARY IS UNLAWFUL.


 


32. NOTICE TO NEW MEXICO RESIDENTS ONLY: THESE
SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES DIVISION OF THE NEW MEXICO DEPARTMENT OF BANKING NOR HAS THE
SECURITIES DIVISION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PRIVATE PLACEMENT MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY
IS A CRIMINAL OFFENSE.


 


33. NOTICE TO NEW YORK RESIDENTS ONLY: THIS
DOCUMENT HAS NOT BEEN REVIEWED BY THE ATTORNEY GENERAL OF THE STATE OF NEW YORK PRIOR TO ITS ISSUANCE AND USE. THE ATTORNEY GENERAL
OF THE STATE OF NEW YORK HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.
THE COMPANY HAS TAKEN NO STEPS TO CREATE AN AFTER MARKET FOR THE SHARES OFFERED HEREIN AND HAS MADE NO ARRANGEMENTS WITH BROKERS
OF OTHERS TO TRADE OR MAKE A MARKET IN THE SHARES. AT SOME TIME IN THE FUTURE, THE COMPANY MAY ATTEMPT TO ARRANGE FOR INTERESTED
BROKERS TO TRADE OR MAKE A MARKET IN THE SECURITIES AND TO QUOTE THE SAME IN A PUBLISHED QUOTATION MEDIUM, HOWEVER, NO SUCH ARRANGEMENTS
HAVE BEEN MADE AND THERE IS NO ASSURANCE THAT ANY BROKERS WILL EVER HAVE SUCH AN INTEREST IN THE SECURITIES OF THE COMPANY OR THAT
THERE WILL EVER BE A MARKET THEREFORE.


 


34. NOTICE TO NORTH CAROLINA RESIDENTS ONLY: IN
MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND
THE TERMS OF THE OFFERING, INCLUDING MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE
SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FORGOING AUTHORITIES HAVE NOT CONFIRMED ACCURACY OR DETERMINED
ADEQUACY OF THIS DOCUMENT. REPRESENTATION TO THE CONTRARY IS UNLAWFUL. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY
AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE
STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO
BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.


 





	16	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


35. NOTICE TO NORTH DAKOTA RESIDENTS ONLY: THESE
SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES COMMISSIONER OF THE STATE OF NORTH DAKOTA NOR HAS THE COMMISSIONER
PASSED UPON THE ACCURACY OR ADEQUACY OF THIS OFFERING. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.


 


36. NOTICE TO OHIO RESIDENTS ONLY: IF AN INVESTOR
ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED
BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 107.03(2) OF THE OHIO SECURITIES LAW AND MAY NOT BE RE-OFFERED
FOR SALE, TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 


37. NOTICE TO OKLAHOMA RESIDENTS ONLY: THESE
SECURITIES ARE OFFERED FOR SALE IN THE STATE OF OKLAHOMA IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION FOR PRIVATE OFFERINGS.
ALTHOUGH A PRIOR FILING OF THIS MEMORANDUM AND THE INFORMATION HAS BEEN MADE WITH THE OKLAHOMA SECURITIES COMMISSION, SUCH FILING
IS PERMISSIVE ONLY AND DOES NOT CONSTITUTE AN APPROVAL, RECOMMENDATION OR ENDORSEMENT, AND IN NO SENSE IS TO BE REPRESENTED AS
AN INDICATION OF THE INVESTMENT MERIT OF SUCH SECURITIES. ANY SUCH REPRESENTATION IS UNLAWFUL.


 


38. NOTICE TO OREGON RESIDENTS ONLY: THE SECURITIES
OFFERED HAVE NOT BEEN REGISTERED WITH THE CORPORATION COMMISSION OF THE STATE OF OREGON UNDER PROVISIONS OF OAR 815 DIVISION 36.
THE INVESTOR IS ADVISED THAT THE COMMISSIONER HAS NOT MADE A CURSORY REVIEW OF THE REGISTRATION STATEMENT AND HAS NOT REVIEWED
THIS DOCUMENT SINCE THE DOCUMENT IS NOT REQUIRED TO BE FILED WITH THE COMMISSIONER. THE INVESTOR MUST RELY ON THE INVESTOR'S OWN
EXAMINATION OF THE COMPANY CREATING THE SECURITIES, AND THE TERMS OF THE OFFERING INCLUDING THE MERITS AND RISKS INVOLVED IN MAKING
AN INVESTMENT DECISION ON THESE SECURITIES.


 


39. NOTICE TO PENNSYLVANIA RESIDENTS ONLY: EACH
PERSON WHO ACCEPTS AN OFFER TO PURCHASE SECURITIES EXEMPTED FROM REGISTRATION BY SECTION 203(d), DIRECTLY FROM THE ISSUER OR AFFILIATE
OF THIS ISSUER, SHALL HAVE THE RIGHT TO WITHDRAW HIS ACCEPTANCE WITHOUT INCURRING ANY LIABILITY TO THE SELLER, UNDERWRITER (IF
ANY) OR ANY OTHER PERSON WITHIN TWO (2) BUSINESS DAYS FROM THE DATE OF RECEIPT BY THE ISSUER OF HIS WRITTEN BINDING CONTRACT OF
PURCHASE OR, IN THE CASE OF A TRANSACTION IN WHICH THERE IS NO BINDING CONTRACT OF PURCHASE, WITHIN TWO (2) BUSINESS DAYS AFTER
HE MAKES THE INITIAL PAYMENT FOR THE SECURITIES BEING OFFERED. IF YOU HAVE ACCEPTED AN OFFER TO PURCHASE THESE SECURITIES MADE
PURSUANT TO AN OFFERING WHICH CONTAINS A NOTICE EXPLAINING YOUR RIGHT TO WITHDRAW YOUR ACCEPTANCE PURSUANT TO SECTION 207(m) OF
THE PENNSYLVANIA SECURITIES ACT OF 1972 (70 PS § 1-207(m), YOU MAY ELECT, WITHIN TWO (2) BUSINESS DAYS AFTER THE FIRST TIME
YOU HAVE RECEIVED THIS NOTICE AND AN OFFERING TO WITHDRAW FROM YOUR PURCHASE AGREEMENT AND RECEIVE A FULL REFUND OF ALL MONEYS
PAID BY YOU. YOUR WITHDRAWAL WILL BE WITHOUT ANY FURTHER LIABILITY TO ANY PERSON. TO ACCOMPLISH THIS WITHDRAWAL, YOU NEED ONLY
SEND A LETTER OR TELEGRAM TO THE ISSUER INDICATING YOUR INTENTION TO WITHDRAW. SUCH LETTER OR TELEGRAM SHOULD BE SENT AND POSTMARKED
PRIOR TO THE END OF THE AFOREMENTIONED SECOND BUSINESS DAY. IF YOU ARE SENDING A LETTER, IT IS PRUDENT TO SEND IT BY CERTIFIED
MAIL, RETURN RECEIPT REQUESTED, TO ENSGTI THAT IT IS RECEIVED AND ALSO EVIDENCE THE TIME WHEN IT WAS MAILED. SHOULD YOU MAKE THIS
REQUEST ORALLY, YOU SHOULD ASK WRITTEN CONFIRMATION THAT YOUR REQUEST HAS BEEN RECEIVED. NO SALE OF THE SECURITIES WILL BE MADE
TO RESIDENTS OF THE STATE OF PENNSYLVANIA WHO ARE NON-ACCREDITED INVESTORS IF THE AMOUNT OF SUCH INVESTMENT IN THE SECURITIES WOULD
EXCEED TTHE COMPANYNTY (20%) OF SUCH INVESTOR'S NET WORTH (EXCLUDING PRINCIPAL RESIDENCE, FURNISHINGS THEREIN AND PERSONAL AUTOMOBILES).
EACH PENNSYLVANIA RESIDENT MUST AGREE NOT TO SELL THESE SECURITIES FOR A PERIOD OF TTHE COMPANYLVE (12) MONTHS AFTER THE DATE OF
PURCHASE, EXCEPT IN ACCORDANCE WITH WAIVERS ESTABLISHED BY RULE OR ORDER OF THE COMMISSION. THE SECURITIES HAVE BEEN ISSUED PURSUANT
TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENT OF THE PENNSYLVANIA SECURITIES ACT OF 1972. NO SUBSEQUENT RESALE OR OTHER DISPOSITION
OF THE SECURITIES MAY BE MADE WITHIN 12 MONTHS FOLLOWING THEIR INITIAL SALE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION, EXCEPT
IN ACCORDANCE WITH WAIVERS ESTABLISHED BY RULE OR ORDER OF THE COMMISSION, AND THEREAFTER ONLY PURSUANT TO AN EFFECTIVE REGISTRATION
OR EXEMPTION.


 





	17	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


40. NOTICE TO RHODE ISLAND RESIDENTS ONLY: THESE
SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE DEPARTMENT OF BUSINESS REGULATION OF THE STATE OF RHODE ISLAND NOR HAS
THE DIRECTOR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.


 


41. NOTICE TO SOUTH CAROLINA RESIDENTS ONLY: THESE
SECURITIES ARE BEING OFFERED PURSUANT TO A CLAIM OF EXEMPTION UNDER THE SOUTH CAROLINA UNIFORM SECURITIES ACT. A REGISTRATION STATEMENT
RELATING TO THESE SECURITIES HAS NOT BEEN FILED WITH THE SOUTH CAROLINA SECURITIES COMMISSIONER. THE COMMISSIONER DOES NOT RECOMMEND
OR ENDORSE THE PURCHASE OF ANY SECURITIES, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF THIS PRIVATE PLACEMENT MEMORANDUM.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.


 


42. NOTICE TO SOUTH DAKOTA RESIDENTS ONLY: THESE
SECURITIES ARE BEING OFFERED FOR SALE IN THE STATE OF SOUTH DAKOTA PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SOUTH DAKOTA
BLUE SKY LAW, CHAPTER 47-31, WITH THE DIRECTOR OF THE DIVISION OF SECURITIES OF THE DEPARTMENT OF COMMERCE AND REGULATION OF THE
STATE OF SOUTH DAKOTA. THE EXEMPTION DOES NOT CONSTITUTE A FINDING THAT THIS MEMORANDUM IS TRUE, COMPLETE, AND NOT MISLEADING,
NOR HAS THE DIRECTOR OF THE DIVISION OF SECURITIES PASSED IN ANY WAY UPON THE MERITS OF, RECOMMENDED, OR GIVEN APPROVAL TO THESE
SECURITIES. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.


 


43. NOTICE TO TENNESSEE RESIDENT ONLY: IN
MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING
THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY
AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.


 


THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY
AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD. EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND THE APPLICABLE
STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO
BEAR THE FINANCIAL RISK OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.


 


44. NOTICE TO TEXAS RESIDENTS ONLY: THE SECURITIES
OFFERED HEREUNDER HAVE NOT BEEN REGISTERED UNDER APPLICABLE TEXAS SECURITIES LAWS AND, THEREFORE, ANY PURCHASER THEREOF MUST BEAR
THE ECONOMIC RISK OF THE INVESTMENT FOR AN INDEFINITE PERIOD OF TIME BECAUSE THE SECURITIES CANNOT BE RESOLD UNLESS THEY ARE SUBSEQUENTLY
REGISTERED UNDER SUCH SECURITIES LAWS OR AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE. FURTHER, PURSUANT TO §109.13 UNDER
THE TEXAS SECURITIES ACT, THE COMPANY IS REQUIRED TO APPRISE PROSPECTIVE INVESTORS OF THE FOLLOWING: A LEGEND SHALL BE PLACED,
UPON ISSUANCE, ON CERTIFICATES REPRESENTING SECURITIES PURCHASED HEREUNDER, AND ANY PURCHASER HEREUNDER SHALL BE REQUIRED TO SIGN
A WRITTEN AGREEMENT THAT HE WILL NOT SELL THE SUBJECT SECURITIES WITHOUT REGISTRATION UNDER APPLICABLE SECURITIES LAWS, OR EXEMPTIONS
THEREFROM.


 


45. NOTICE TO UTAH RESIDENTS ONLY: THESE SECURITIES
ARE BEING OFFERED IN A TRANSACTION EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE UTAH SECURITIES ACT. THE SECURITIES CANNOT
BE TRANSFERRED OR SOLD EXCEPT IN TRANSACTIONS WHICH ARE EXEMPT UNDER THE ACT OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT OR IN A TRANSACTION WHICH IS OTHERWISE IN COMPLIANCE WITH THE ACT.


 


46. NOTICE TO VERMONT RESIDENTS ONLY: THESE
SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES DIVISION OF THE STATE OF VERMONT NOR HAS THE COMMISSIONER PASSED
UPON THE ACCURACY OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.


 


47. NOTICE TO VIRGINIA RESIDENTS ONLY: IF AN
INVESTOR ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND
ACQUIRED BY IT/HIM/HER IN A TRANSACTION UNDER SECTION 13.1-514 OF THE VIRGINIA SECURITIES ACT AND MAY NOT BE RE-OFFERED FOR SALE,
TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 





	18	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


48. NOTICE TO WASHINGTON RESIDENTS ONLY: THE
ADMINISTRATOR OF SECURITIES HAS NOT REVIEWED THE OFFERING OR PRIVATE PLACEMENT MEMORANDUM AND THE SECURITIES HAVE NOT BEEN REGISTERED
IN RELIANCE UPON THE SECURITIES ACT OF WASHINGTON, CHAPTER 21.20 RCW, AND THEREFORE, CANNOT BE RESOLD UNLESS THEY ARE REGISTERED
UNDER THE SECURITIES ACT OF WASHINGTON, CHAPTER 21.20 RCW, OR UNLESS AN EXEMPTION FROM REGISTRATION IS MADE AVAILABLE.


 


49. NOTICE TO WEST VIRGINIA RESIDENTS ONLY: IF
AN INVESTOR ACCEPTS AN OFFER TO PURCHASE ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND
ACQUIRED BY IT/HIM/HER IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 15.06(b)(9) OF THE WEST VIRGINIA SECURITIES LAW
AND MAY NOT BE REOFFERED FOR SALE, TRANSFERRED, OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.


 


50. NOTICE TO WISCONSIN RESIDENTS ONLY: IN ADDITION
TO THE INVESTOR SUITABILITY STANDARDS THAT ARE OTHERWISE APPLICABLE, ANY INVESTOR WHO IS A WISCONSIN RESIDENT MUST HAVE A NET WORTH
(EXCLUSIVE OF HOME, FURNISHINGS AND AUTOMOBILES) IN EXCESS OF THREE AND ONE-THIRD (3 1/3) TIMES THE AGGREGATE AMOUNT INVESTED BY
SUCH INVESTOR IN THE SHARES OFFERED HEREIN.


 


51. FOR WYOMING RESIDENTS ONLY: ALL WYOMING
RESIDENTS WHO SUBSCRIBE TO PURCHASE SHARES OFFERED BY THE COMPANY MUST SATISFY THE FOLLOWING MINIMUM FINANCIAL SUITABILITY REQUIREMENTS
IN ORDER TO PURCHASE SHARES: (1) A NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS AND AUTOMOBILES) OF TWO HUNDRED FIFTY THOUSAND DOLLARS
($250,000); AND (2) THE PURCHASE PRICE OF SHARES SUBSCRIBED FOR MAY NOT EXCEED TWENTY PERCENT (20%) OF THE NET WORTH OF THE SUBSCRIBER;
AND (3) "TAXABLE INCOME" AS DEFINED IN SECTION 63 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, DURING THE LAST TAX
YEAR AND ESTIMATED "TAXABLE INCOME" DURING THE CURRENT TAX YEAR SUBJECT TO A FEDERAL INCOME TAX RATE OF NOT LESS THAN
THIRTY-THREE PERCENT (33%). IN ORDER TO VERIFY THE FOREGOING, ALL SUBSCRIBERS WHO ARE WYOMING RESIDENTS WILL BE REQUIRED TO REPRESENT
IN THE SUBSCRIPTION AGREEMENT THAT THEY MEET THESE WYOMING SPECIAL INVESTOR SUITABILITY REQUIREMENTS.


 


ANTI-MONEY
LAUNDERING REGULATIONS


 


The
Company may require a detailed verification of your identity and the source of the payment for the common stock. Depending
on the circumstances, a detailed verification might not be required where (a) you are
regulated by a recognized regulatory authority, or (b) the Subscription is made through
an intermediary who is regulated by a recognized regulatory authority. In this situation, The Company may rely on a written assurance
from the intermediary that the requisite identification procedures in respect of the
subscriber have been carried out. These exceptions will only apply if you or intermediary
referred to above are within a country recognized as having sufficient anti-money
laundering regulations.


 


The
Company reserves the right to request such information as is necessary to verify your identity. In the event of delay
or failure to produce any information required for verification purposes, The Company may refuse to accept the
Subscription Agreement and the Subscription monies relating thereto. If any person has a suspicion that a payment to us (by way
of Subscription or otherwise) contains the proceeds of criminal conduct or has a suspicion obtained in the course of business that
any other person is engaged in money laundering that person is required to report such
suspicion and such report shall not be treated as a breach of any restriction upon
disclosure of information imposed by any enactment or otherwise


 


USA PATRIOT
ACT


 


In
addition to the foregoing requirements, you will be required to comply with the additional verification requirements
set forth in the Subscription Agreement for the Common stock, as required by the USA PATRIOT Act and applicable regulations.
The Company may in the future request additional information and/or representations to comply
with the PATRIOT Act and regulations.


 





	19	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    

 


 


During
the course of the Offering and prior to any sale, each offeree of the Shares and his or her professional advisor(s), if any, are
invited to ask questions concerning the terms and conditions of the Offering and to obtain any additional information necessary
to verify the accuracy of the information set forth herein. Such information will be provided to the extent The Company possess
such information or can acquire it without unreasonable effort or expense.


 


EACH PROSPECTIVE INVESTOR WILL
BE GIVEN AN OPPORTUNITY TO ASK QUESTIONS OF, AND RECEIVE ANSTHE COMPANYRS FROM, MANAGEMENT OF THE COMPANY CONCERNING THE TERMS
AND CONDITIONS OF THIS OFFERING AND TO OBTAIN ANY ADDITIONAL INFORMATION, TO THE EXTENT THE COMPANY POSSESSES SUCH INFORMATION
OR CAN ACQUIRE IT WITHOUT UNREASONABLE EFFORTS OR EXPENSE, NECESSARY TO VERIFY THE ACCURACY OF THE INFORMATION CONTAINED IN THIS
MEMORANDUM. IF YOU HAVE ANY QUESTIONS WHATSOEVER REGARDING THIS OFFERING, OR DESIRE ANY ADDITIONAL INFORMATION OR DOCUMENTS TO
VERIFY OR SUPPLEMENT THE INFORMATION CONTAINED IN THIS MEMORANDUM, PLEASE WRITE OR CALL:


 


Robert Goldstein


US Nuclear Corp. Inc.


President and Chief Executive Officer


7051 Eton Avenue


Canoga Park, California 91303


(818) 883-7043





 


 


 


 


	20	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017







 




    	



    	 



    

Exhibit
A – ACCREDITED investor Questionnaire


This Accredited Investor
Questionnaire is intended to assess interest in participation in the offering of common stock of the Company as an accredited investor.
We ask that you please complete and return this Accredited Investor Questionnaire regardless of whether you wish to participate
in the Offering.


This questionnaire
is not intended to be, and does not constitute, an offer to sell or the solicitation of an offer to buy any security. No binding
agreement or obligation of any kind shall be created by this questionnaire.


1.       Print
Name of Potential Investor: ______________________________________________________


2.       Please
select one of the following options:


( )Participation
Interest


If you are interested
in participating in the Offering, please indicate the maximum dollar amount you are interested in investing:


Maximum Amount
of Desired Investment:


$___________________________________


( )No Participation
Interest


If you are not
interested in participating the Offering, please place an “X” here: _______


3.       Participation
in the Offering following completion of this Accredited Investor Questionnaire is available only to the “accredited investor.”
Please note that the Company is also entertaining offers up to 35 non-accredited, but sophisticated investors. In completing this
Accredited Investor Questionnaire, please refer to the definitions below. Please place an “X” in the appropriate box
below to indicate your status (ONLY ONE BOX NEEDS TO BE CHECKED; CONTACT THE COMPANY IF NONE IS APPLICABLE):


“Accredited investor”
means any person who comes within any of the following categories:


(1)Any natural person
whose individual net worth, or joint net worth with that person's spouse, at the time of the purchase exceeds $1,000,000. [______]


(2)Any natural person
who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person's spouse
in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current
year.  [______]


(3) Any bank as defined
in Section 3(a)(2) of the Securities Act of 1933, as amended (the “Act”), or any savings and loan association or other
institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; any broker dealer
registered pursuant to Section 15 of the Securities Exchange Act of 1934; any insurance company as defined in Section 2(13) of
the Act; any investment company registered under the Investment Company Act of 1940 or a business development company as defined
in Section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under
Section 301(c) or (d) of the Small Business Investment Act of 1958; any plan established and maintained by a state, its political
subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such
plan has total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security
Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a
bank, savings and loan association, insurance company, or registered investment advisor, or if the employee benefit plan has total
assets in excess of $5,000,000, or, if a self-directed plan, with investment decisions made solely by persons that are accredited
investors. [______]


(4) Any private business
development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940. [______]


(5)Any organization
described in Section 501(c)(3) of the Internal Revenue Code, corporation, company, or similar business trust, or Company, not formed
for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000.  [______]


(6)Any director, executive
officer, or Company of the issuer of the securities being offered or sold, or any director, executive officer, or Company of a
Company of that issuer. [______]





	21	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    

 


(7)Any trust
with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase
is directed by a sophisticated person as described in Rule 506(b)(2)(ii).  [______]


(8)Any entity in which
all of the equity owners are accredited investors.[______]


4.       Reliance.
I understand you will be relying on my representations. If there is any material change in the information provided to you prior
to your acceptance of the Subscription Agreement, I will immediately provide you with information regarding such change. Furthermore,
the Executive Summary will be provided upon completion of this Questionnaire, and once produced will be incorporated herein.


Please note that because
the amount of the Offering is limited, we cannot assure you that you will be able to participate in the Offering at your desired
investment level, or at all. Allocation of the available Offering amount will be made by Company, in its sole and absolute discretion.



5.       Signature.
The undersigned has executed this Investor Questionnaire on ____________ ____, 2016.


 


Print Name of Potential
Investor: _____________________________________________________________


 


Signature: ___________________________________________________________________


 


Address:___________________________________________________________________


___________________________________________________________________


___________________________________________________________________


 


Phone:___________________________________________________________________


Fax:___________________________________________________________________


Contact: ___________________________________________________________________


 


If the Investor is an
entity, also complete the following:


 


Name of Signatory: _______________________________________________


 


Title: _____________________________________________________





	22	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017









    	



    	 



    

Exhibit
b - SUbscription agreement


This Subscription Agreement
(this “Agreement”), with an effective date as of the date of purchase by the Subscriber, as identified below, regardless
of the actual date of execution by the parties, by and between US Nuclear Corp., a Delaware corporation, (the “Company”),
and the signatory on the signature page hereto (“Subscriber”).


WHEREAS, the Company and
the Subscriber are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded
by the provisions of Section 4(2), Section 4(6) and/or Regulation D (“Regulation D”) as promulgated by the United States
Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933
Act”); and


WHEREAS, the parties desire
that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Subscriber, and the
Subscriber shall subscribe to and purchase common stock in the Company (the “Common Stock”).


NOW, THEREFORE, in consideration
of the mutual covenants and other agreements contained in this Agreement the Company and the Subscriber hereby agree as follows:


1. Purchase and Sale. The Company has offered
for sale, and the undersigned Subscriber hereby tenders this subscription and applies for the purchase of, the applicable number
of the Common stocks at the applicable purchase price (the “Purchase Price”) all as set forth on the signature page
hereto (the “Signature Page”). Together with this Subscription Agreement, the Subscriber is delivering to the Company
the full amount of the Purchase Price for the Common Stock. This subscription may be rejected by the Company in its sole discretion
in whole or in part. THE SIGNATURE OF THE UNDERSIGNED ON THE SIGNATURE PAGE CONSTITUTES THE EXECUTION OF THIS SUBSCRIPTION AGREEMENT.


 


2. Closing and Conditions to Closing.


 


3. Closing. The consummation of the transactions
contemplated herein shall take place at the offices of the Company, as soon as practicable following the satisfaction or waiver
of all conditions to closing set forth in this Agreement (the “Closing Date”). Subject to the satisfaction or waiver
of the terms and conditions of this Agreement, on the Closing Date, Subscriber shall purchase and the Company shall sell to Subscriber
the applicable number of Common Stock for the applicable Purchase Price.


 


4. Conditions to Closing. As a condition precedent
to closing, the Subscriber shall approve, consent to and agree to be bound by the terms, conditions and other provisions of the
Company’s Bylaws.


 


5. Subscriber’s Representations and Warranties.
Subscriber hereby represents and warrants to and agrees with the Company that:


 


(a) If an entity, Subscriber
is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization.


 


(b)
Subscriber has the requisite power and authority to enter into and perform this Agreement and to purchase the Common Stock
being sold to it hereunder. The execution, delivery and performance of this Agreement by Subscriber
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action,
and no further consent or authorization of such Subscriber is required. This Agreement has been duly authorized, executed and delivered
by Subscriber and constitutes, or shall constitute when executed and delivered, a valid and binding obligation of the Subscriber
enforceable against the Subscriber in accordance with the term hereof.


 


(c)
The execution, delivery and performance of this Agreement and the consummation by Subscriber of the transactions contemplated hereby
or relating hereto do not and will not (i) result in a violation of such Subscriber’s charter documents or bylaws or other
organizational documents or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of any agreement,
indenture or instrument or obligation to which Subscriber is a party or by which its properties or assets are bound, or result
in a violation of any law, rule, or regulation, or any order, judgment or decree of any court or governmental agency applicable
to Subscriber or its properties (except for such conflicts, defaults and violations as would not, individually or in the aggregate,
have a material adverse effect on Subscriber). Subscriber is not required to obtain any consent, authorization or order of, or
make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its
obligations under this Agreement or to purchase the  Common Stock in accordance with the terms
hereof, provided that for purposes of the representation made in this sentence, Subscriber is assuming and relying upon the accuracy
of the relevant representations and agreements of the Company herein.


 





	23	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    

 


 


(d) The Subscriber has
received in writing from the Company such information concerning its operations, financial condition and other matters as the Subscriber
has requested in writing (such information is collectively, the “Company Information”), and considered all factors
the Subscriber deems material in deciding on the advisability of investing in the Securities.


 


(e) The Subscriber is,
and will be on the Closing Date, an “accredited investor”, as such term is defined in Regulation D promulgated by the
Commission under the 1933 Act, or is considered a sophisticated investor, and is experienced in investments and business matters,
has made investments of a speculative nature and has purchased securities of United States privately-owned companies in private
placements in the past and, with its representatives, has such knowledge and experience in financial, tax and other business matters
as to enable the Subscriber to utilize the information made available by the Company to evaluate the merits and risks of and to
make an informed investment decision with respect to the proposed purchase of the Common Stock, which represents a speculative
investment. The Subscriber is able to bear the risk of such investment for an indefinite period and to afford a complete loss thereof.
The information set forth on the signature page hereto regarding the Subscriber is accurate.


 


(f) The Subscriber understands
and agrees that the Common Stock has not been registered under the 1933 Act or any applicable state securities laws, by reason
of their issuance in a transaction that does not require registration under the 1933 Act (based in part on the accuracy of the
representations and warranties of Subscriber contained herein), and that the Common Stock must be held indefinitely unless a subsequent
disposition is registered under the 1933 Act or any applicable state securities laws or is exempt from such registration. Notwithstanding
anything to the contrary contained in this Agreement, Subscriber may transfer (without restriction and without the need for an
opinion of counsel) the Common Stock to its Affiliates (as defined below) provided that each such Affiliate is an “accredited
investor” under Regulation D and such Affiliate agrees to be bound by the terms and conditions of this Agreement. For the
purposes of this Agreement, an “Affiliate” of any person or entity means any other person or entity directly or indirectly
controlling, controlled by or under direct or indirect common control with such person or entity. Affiliate when employed in connection
with the Company includes each Subsidiary as defined in Section 4(a) of this Agreement. For purposes of this definition, “control”
means the power to direct the management and policies of such person or firm, directly or indirectly, whether through the ownership
of voting securities, by contract or otherwise.


 


(g) The offer to sell the
Common Stock was directly communicated to the Subscriber by the Company. At no time was the Subscriber presented with or solicited
by any leaflet, newspaper or magazine article, radio or television advertisement, or any other form of general advertising or solicited
or invited to attend a promotional meeting otherwise than in connection and concurrently with such communicated offer.


 


(h) The Subscriber intends
on holding the Common Stock in its/his/her personal account without the intent of public distribution.


 


6. No Governmental Review. Subscriber understands
that no United States federal or state agency or any other governmental or state agency has passed on or made recommendations or
endorsement of the Common Stock or the suitability of the investment in the Common stocks nor have such authorities passed upon
or endorsed the merits of the offering of the Common Stock.


 


7. Correctness of Representations. Subscriber
represents that the foregoing representations and warranties are true and correct as of the date hereof and, unless such Subscriber
otherwise notifies the Company prior to the Closing Date shall be true and correct as of the Closing Date.


 





	24	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017




 






    	



    	 



    




8. Survival. The foregoing representations and
warranties shall survive the Closing Date for a period of one year after the Closing Date.


 


9. Company Representations and Warranties. The
Company represents and warrants to and agrees with Subscriber that:


 


(a) The Company is a corporation
incorporated, validly existing and in good standing under the laws of the State of Delaware and has the requisite corporate power
to own its properties and to carry on its business as it is currently conducted.


 


(b) All issued and outstanding
stock of the Company have been duly authorized and validly issued and are fully paid and non-assessable, and all such stock of
the Company have been issued in compliance with all applicable federal and state securities laws.


 


(c) This Agreement and
any other agreements delivered together with this Agreement or in connection herewith (collectively “Transaction Documents”)
have been duly authorized, executed and delivered by the Company and are valid and binding agreements enforceable against the Company
in accordance with their respective terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and
similar laws of general applicability relating to or affecting creditors’ rights generally and to general principles of equity.
The Company has full corporate power and authority necessary to enter into and deliver the Transaction Documents and to perform
its obligations thereunder.


 


(d) No consent, approval,
authorization or order of any court, governmental agency or body or arbitrator having jurisdiction over the Company, or any of
its Affiliates, nor the Company’s Members is required for the execution by the Company of the Transaction Documents and compliance
and performance by the Company of its obligations under the Transaction Documents, including, without limitation, the issuance
and sale of the Common Stock.


 


(e) Assuming the representations
and warranties of the Subscriber in Section 5 are true and correct, neither the issuance and sale of the Common Stock nor the performance
of the Company’s obligations under this Agreement and all other agreements entered into by the Company relating thereto by
the Company will violate, conflict with, result in a breach of, or constitute a default (or an event which with the giving of notice
or the lapse of time or both would be reasonably likely to constitute a default in any material respect) under (i) the articles
of incorporation of the Company, (ii) to the Company’s knowledge, any decree, judgment, order, law, treaty, rule, regulation
or determination applicable to the Company of any court, governmental agency or body, or arbitrator having jurisdiction over the
Company or over the properties or assets of the Company or any of its Affiliates, (iii) the terms of any common stock, debenture,
note or any other evidence of indebtedness, or any agreement, unit option or other similar plan, indenture, lease, mortgage, deed
of trust or other instrument to which the Company or any of its Affiliates is a party, by which the Company or any of its Affiliates
is bound, or to which any of the properties of the Company or any of its Affiliates is subject, or (iv) the terms of any “lock-up”
or similar provision of any underwriting or similar agreement to which the Company, or any of its Affiliates is a party.


 


(f) Except as described
in the Company Information, there is no pending or, to the best knowledge of the Company, basis for or threatened action, suit,
proceeding or investigation before any court, governmental agency or body, or arbitrator having jurisdiction over the Company,
or any of its Affiliates to which the Company or any of its Affiliates is a party or which could adversely affect the Company or
any of its Subsidiaries or the business conducted or proposed to be conducted by any of them.


 


10. Regulation D Offering. The offer, issuance
and sale of the Common Stock to the Subscriber is being made pursuant to the exemption from the registration provisions of the
1933 Act afforded by Section 4(2) or Section 4(6) of the 1933 Act and/or Rule 506 of Regulation D promulgated thereunder.


 


11. Broker’s Commission. The
Company represents that there are no parties entitled to receive fees, commissions, or similar payments in connection with the
offering described in this Agreement.


 


12. Legal Fees. Each party shall pay their own
legal fees incurred in connection with the transaction contemplated herein, including, but not limited to, the drafting and negotiation
of the Transaction Documents.


 





	25	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




13. Covenants of the Company. The Company covenants
and agrees with the Subscriber as follows:


 


(a) The proceeds of this
offering will be utilized in accordance with the Use of Proceeds, as described in detail in the Company’s Private Placement
Memorandum for the purpose of working capital and general administrative expenses and professional fees.


 


(b) No press release notice,
disclosure or any other publicity concerning the transactions set forth herein shall be issued, given or disseminated by either
party without the approval of the other party.


 


(c) The Company agrees
to indemnify, hold harmless, reimburse and defend the Subscriber, the Subscriber’s officers, directors, agents, Affiliates,
control persons, and principal shareholders, against any claim, cost, expense, liability, obligation, loss or damage (including
reasonable legal fees) of any nature, incurred by or imposed upon the Subscriber or any such person which results, arises out of
or is based upon (i) any misrepresentation by Company or breach of any warranty by Company in this Agreement or in any Schedules
attached hereto, or other agreement delivered pursuant hereto; or (ii) after any applicable notice and/or cure periods, any breach
or default in performance by the Company of any covenant or undertaking to be performed by the Company hereunder, or any other
agreement entered into by the Company and Subscriber relating hereto.


 


14. Covenants of the Subscriber. Subscriber
agrees to indemnify, hold harmless, reimburse and defend the Company and each of the Company’s officers, directors, agents,
Affiliates, control persons against any claim, cost, expense, liability, obligation, loss or damage (including reasonable legal
fees) of any nature, incurred by or imposed upon the Company or any such person which results, arises out of or is based upon (i)
any misrepresentation by such Subscriber in this Agreement or in any Schedule attached hereto, or other agreement delivered pursuant
hereto; or (ii) after any applicable notice and/or cure periods, any breach or default in performance by such Subscriber of any
covenant or undertaking to be performed by such Subscriber hereunder, or any other agreement entered into by the Company and Subscriber,
relating hereto.


 


15. Miscellaneous.


 


(a) All notices, demands,
requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise
specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested,
postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram,
or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written
notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (i) upon hand delivery
or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number
designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first
business day following such delivery (if delivered other than on a business day during normal business hours where such notice
is to be received) or (ii) on the second business day following the date of mailing by express courier service, fully prepaid,
addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications
shall be to the Company at the address first stated hereinabove.


 


(b) This Agreement and
the Transaction Documents delivered in connection herewith represent the entire agreement between the parties hereto with respect
to the subject matter hereof and may be amended only by a writing executed by both parties. Neither the Company nor the Subscriber
has relied on any representations not contained or referred to in this Agreement and the documents delivered herewith. No right
or obligation of the Company shall be assigned except to an Affiliate without prior notice to and the written consent of the Subscriber.


 


(c) This Agreement may
be executed in any number of counterparts and by the different signatories hereto on separate counterparts, each of which, when
so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument. This Agreement
may be executed by facsimile signature and delivered by facsimile transmission.


 


(d) This Agreement shall
be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of laws principles
that would result in the application of the substantive laws of another jurisdiction. Any action brought by either party against
the other concerning the transactions contemplated by this Agreement shall be brought only in the civil or state court located
in the City of Los Angeles, State of California (the situs of the Company’s main offices) or in the United States District
Court for the Central District of California in Los Angeles, California. The parties and
the individuals executing this Agreement and other agreements referred to herein or delivered in connection herewith on behalf
of the Company agree to submit to the jurisdiction of such courts and waive trial by jury. The prevailing party shall be
entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this
Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified
to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not
affect the validity or enforceability of any other provision of any agreement.


 





	26	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


(e) To the extent permitted
by law, the Company and Subscriber acknowledge and agree that irreparable damage would occur in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that the parties shall be entitled to one or more preliminary and final injunctions to prevent or cure breaches of the provisions
of this Agreement and to enforce specifically the terms and provisions hereof, this being in addition to any other remedy to which
any of them may be entitled by law or equity. Subject to Section 10(d) hereof, each of the Company, Subscriber and any signator
hereto in his personal capacity hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction in California of such court, that the suit, action or proceeding is brought in
an inconvenient forum or that the venue of the suit, action or proceeding is improper. Nothing in this Section shall affect or
limit any right to serve process in any other manner permitted by law.


 


(f) Nothing contained herein
or in any document referred to herein or delivered in connection herewith shall be deemed to establish or require the payment of
a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest
or dividends required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess of
such maximum shall be credited against amounts owed by the Company to the Subscriber and thus refunded to the Company.


 


[SIGNATURES ON NEXT PAGE]


 





	27	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017









    	



    	 



    

 


 


Please acknowledge your acceptance
of the foregoing Subscription Agreement by signing and returning a copy to the undersigned whereupon it shall become a binding
agreement between us.


 


US NUCLEAR CORP.


 


 


By:______________________________________________________


Name: Robert I. Goldstein


Its:Chief Executive Officer and President


 


Dated: 


 


	SUBSCRIBER	PURCHASE PRICE	NUMBER OF COMMON STOCKS 	PERCENTAGE INTEREST
	
         

         

        ________________________________

        By:

        Its:

         

        Address:
	
         

        $
	 	 





 


 


 


 


	28	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017









    	



    	 



    

 


Exhibit
C – Link to Annual Report for 2015 (Financial and Operational Disclosures)


 


FORM 10-K (2015) – Annual
Report and audited financials


 


www.sec.gov/Archives/edgar/data/1543623/000165917316000242/ucle201510kv3.htm


 


FORM 10-Q (3rd Quarter
2016) – QUARTERLY REPORT AND UNAUDITED BUT REVIEWED FINANCIALS


 


www.sec.gov/Archives/edgar/data/1543623/000165917316000608/usnuclear10q320161110.htm


 





	29	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    

 




Exhibit
D – BUSINESS Presentation


 


 


 


 











	30	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    










	31	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	32	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	33	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	34	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	35	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	36	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	37	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	38	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	39	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	40	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    










	41	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	42	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	43	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	44	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	45	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    







	46	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 


 


Exhibit
E – Corporate Resolutions: Offering Extensions








	47	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017








    	



    	 



    




 








	48	US Nuclear Corp.                                                                                        December 1, 2016 to May 31, 2017